sertraline has been researched along with Depression in 378 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.26) | 18.7374 |
| 1990's | 40 (10.58) | 18.2507 |
| 2000's | 105 (27.78) | 29.6817 |
| 2010's | 173 (45.77) | 24.3611 |
| 2020's | 59 (15.61) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, J; Gao, S; Li, G; Sun, T; Xing, Y; Xu, G | 1 |
| Bohn, J; Dutcher, S; Lyons, JG; Mosholder, AD; Pennap, DD; Swain, RS; Welch, EC | 1 |
| Jin, CH; Jin, GN; Jin, X; Lan, HW; Lu, JM; Lu, YN; Ma, J; Piao, LX; Xu, X; Zhao, XD | 1 |
| Hsu, CW; Kao, HY; Lin, PY; Tseng, WT; Wang, LJ; Yang, YH | 1 |
| Li, G; Liu, W; Wang, C; Wang, X; Yang, L | 1 |
| Gormus, ZIS; Gunes, CE; Koca, RO; Kutlu, S; Solak, H | 1 |
| Breitinger, S; Frye, MA; Gardea-Resendez, M; Gerberi, DJ; Nuñez, NA; Park, JH; Singh, B; Veldic, M | 1 |
| Finn, DP; Joshi, A; McClean, PL; Todd, S; Wong-Lin, K | 1 |
| Abramkin, AA; Glukhova, SI; Kovalevskaya, OB; Lisitsyna, TA; Nasonov, EL; Seravina, OF; Veltishchev, DY | 2 |
| Alexopoulos, GS; Bingham, KS; Flint, AJ; Marino, P; Meyers, BS; Mulsant, BH; Neufeld, NH; Rothschild, AJ; Voineskos, AN; Whyte, EM | 1 |
| Alexopoulos, GS; Flint, AJ; Gerretsen, P; Marino, P; Meyers, BS; Mulsant, BH; Rothschild, AJ; Sanches, M; Song, J; Voineskos, AN; Whyte, EM | 1 |
| Carlisle, N; Chidharom, M; Etkin, A; Fonzo, GA; Tong, X; Xie, H; Zhang, Y; Zhao, K | 1 |
| Batelaan, NM; Han, LKM; Hoogendoorn, AW; Hu, MX; Lever-van Milligen, BA; Penninx, BWJH; Révész, D; van Balkom, AJLM; van Oppen, P; van Schaik, DJF; Verhoeven, JE | 1 |
| Alexopoulos, GS; Elsheikh, SS; Flint, AJ; Kennedy, JL; Marino, P; Marshe, V; Men, X; Meyers, BS; Müller, DJ; Mulsant, BH; Rothschild, AJ; Voineskos, AN; Whyte, EM | 1 |
| Chen, M; Fan, J; Guo, C; Liu, W; Liu, Y; Lu, H; Xu, J; Yang, J; Zhang, H | 1 |
| Christensen, KS; Gasse, C; Ishtiak-Ahmed, K | 1 |
| Alexopoulos, GS; Bingham, KS; Butters, MA; Calarco, N; Dickie, EW; Flint, AJ; Marino, P; Meyers, BS; Mulsant, BH; Neufeld, NH; Rothschild, AJ; Voineskos, AN; Whyte, EM | 1 |
| Cao, Q; Rao, Y; Yang, R; Zhao, J | 1 |
| Ilic, N; Jankovic, SM; Milovanovic, J; Nikolic, VN; Popovic, D; Stoiljkovic, M; Vujovic, M | 1 |
| Zhang, J; Zhao, Z; Zheng, X | 1 |
| Fan, Y; Gao, R; Liu, W; Wang, J; Wang, S; Wu, L; Xu, H; Xu, L; Yao, H; Yu, J; Yu, Z; Zhang, J; Zhang, L; Zhou, M | 1 |
| Chen, Y; Li, J; Liu, Y; Luo, X; Ren, M; Si, T; Zhu, D | 1 |
| Hedayati, A; Hosseini, FA; Shaygan, M; Shemiran, M | 1 |
| Brand, S; Brühl, AB; Davarinejad, O; Shahmoradi, N | 1 |
| Al-Janabi, H; Au, P; Barnes, NM; Barnes, TRE; Birchwood, M; Drake, R; Giacco, D; Griffiths, SL; Husain, N; Katshu, MZUH; Major, B; Marriott, C; Ottridge, R; Palmer, ER; Patel, S; Sadiq, Z; Taylor, E; Tearne, S; Upthegrove, R; Walters, JTR; Watkins, B; Weetman, T; Woolley, R | 1 |
| Petelin, DS; Volel', BA | 1 |
| Bolding, IJ; Boone, DR; Cardenas, C; DeWitt, DS; Falduto, MT; Hellmich, HL; Micci, MA; Prough, DS; Sell, SL; Torres, KEO; Weisz, HA; Willey, HE | 1 |
| Penninx, B | 1 |
| Goldstein-Piekarski, AN; Korgaonkar, MS; Tozzi, L; Williams, LM | 1 |
| Bråten, LS; Haslemo, T; Ingelman-Sundberg, M; Jukic, MM; Kringen, MK; Molden, E | 1 |
| Orgeta, V; Stafford, J; Tuijt, R; Verdaguer, ES | 1 |
| Coffey, BJ; Mendelsohn, J | 1 |
| Braillon, A; Gluud, C; Hengartner, MP; Jakobsen, JC; Plöderl, M | 1 |
| Munkholm, K; Paludan-Müller, AS | 1 |
| Arroll, B | 1 |
| Lewis, G | 1 |
| Andrade, C; Nachane, H; Sasikumaran, A; Sharma, N | 1 |
| Aguglia, E; Migliore, M; Signorelli, MS; Surace, T | 1 |
| Bates, DW; Buckeridge, DL; Dixon, WG; Girard, N; Haas, JS; Habib, B; Iqbal, U; Li, J; Sheppard, T; Tamblyn, R | 1 |
| Frecska, E; Mathe, E; More, C; Szoke-Kovacs, R; Szoke-Kovacs, Z | 1 |
| Choi, WJ; Kim, B; Kim, S; Kim, WJ; Park, JY; Park, S; Roh, D; Son, SJ | 1 |
| Brennecke, A; Weaver, DF | 1 |
| Abe, K; Hishikawa, N; Matsumoto, N; Nomura, E; Ohta, Y; Omote, Y; Sasaki, R; Tadokoro, K; Takemoto, M; Tsunoda, K; Yamashita, T | 1 |
| Ben Omar, N; Endres, K; Gaebler, AJ; Haen, E; Hiemke, C; Paulzen, M; Schoretsanitis, G | 1 |
| Akechi, T; Debray, TPA; Efthimiou, O; Furukawa, TA; Kato, T; Seo, M; Yamada, M | 1 |
| Jiang, W; Li, R; Li, Y; Ma, L; Wang, G; Xu, Y; Zhang, X; Zhou, J | 1 |
| Hagag, RS; Hamed, MGM | 1 |
| Babyak, MA; Blumenthal, JA; Craighead, WE; Davidson, J; Doraiswamy, PM; Hinderliter, A; Hoffman, B; Sherwood, A | 1 |
| Li, WH; Liu, XF; Wei, ZW | 1 |
| Coffey, BJ; Jaffe, RJ; McCoy, B | 1 |
| Alexopoulos, GS; Banerjee, S; Flint, AJ; Marino, P; Meyers, BS; Mulsant, BH; Pollari, CD; Rothschild, AJ; Voineskos, AN; Whyte, EM; Wu, Y | 1 |
| Benites-Zapata, VA; Brañez-Condorena, A; Chambergo-Michilot, D; Falvy-Bockos, I; Pacheco-Mendoza, J | 1 |
| Ahmed, N; Bone, JK; Duffy, L; Freemantle, N; Harmer, CJ; Lewis, G | 1 |
| Avramopoulos, D; Brasic, J; Dannals, RF; Gould, NF; Hall, AW; Holt, DP; Joo, JH; Kraut, M; Kuwabara, H; Mathews, WB; Nandi, A; Nassery, N; Savonenko, A; Smith, GS; Workman, CI | 1 |
| Li, YH; Lian, JL; Sun, X; Wang, YJ; Wu, XM | 1 |
| Akhondzadeh, S; Ansari, S; Esalatmanesh, S; Ghazizadeh-Hashemi, M; Hossein Rashidi, B; Kashani, L; Masoudi, M; Noorbala, AA; Tavolinejad, H | 1 |
| Allard, CB; Kim, HM; Norman, SB; Rauch, SAM; Simon, NM; Stein, MB; Straus, E | 1 |
| Bai, Y; He, Y; Huang, J; Huang, S; Huang, W; Li, H; Li, Y | 1 |
| Bernardes, LB; Bochi, GV; Dalenogare, DP; de David Antoniazzi, CT; Ferreira, J; Fialho, MFP; Kudsi, SQ; Lückemeyer, DD; Mello, FK; Oliveira, SM; Pereira, GC; Peres, DS; Rodrigues, P; Ruviaro da Silva, NA; Sampaio, TB; Theisen, MC; Trevisan, G | 1 |
| Cao, C; Chen, LH; Fan, Y; Hu, H; Jiang, C; Li, Y; Liu, J; Liu, T; Luo, W; Tang, Z; Wu, W; Xu, Y; Zhang, Q | 1 |
| Abi Zeid Daou, M; Albert, K; Boyd, BD; Donahue, MJ; Taylor, WD | 1 |
| Acion, L; Jones, M; Jorge, RE | 1 |
| Amore, M; Belvederi Murri, M; Bertolotti, M; Ceresini, G; Cremonini, A; Ferrari, S; Menchetti, M; Mussi, C; Neri, G; Neri, M; Neviani, F; Simoncini, E; Squatrito, S; Toni, G; Triolo, F; Tripi, F; Zanetidou, S | 1 |
| Cooper, AA; Feeny, NC; Mavissakalian, MR; Roy-Byrne, P; Zoellner, LA | 1 |
| Appt, SE; Carr, JJ; Groban, L; Justice, JN; Kitzman, DW; Register, TC; Shively, CA; Silverstein-Metzler, MG | 1 |
| Kheshti, R; Maryam, M; Tavakoli-Ardakani, M | 1 |
| Ades, A; Araya, R; Button, KS; Churchill, R; Croudace, T; Derrick, C; Dixon, P; Dowrick, C; Duffy, L; Gilbody, S; Hollingworth, W; Jones, V; Kendrick, T; Kessler, D; Kounali, D; Lanham, P; Lewis, G; Malpass, A; Peters, TJ; Riozzie, D; Robinson, J; Salaminios, G; Sharp, D; Thomas, L; Welton, NJ; Wiles, N | 1 |
| Appt, SE; Clarkson, TB; Justice, JN; Kritchevsky, SB; Register, TC; Shively, CA; Silverstein-Metzler, MG; Uberseder, B | 1 |
| Carmody, T; Gregg, LP; Hedayati, SS; Jain, N; Rush, AJ; Toto, RD; Toups, M; Trivedi, MH | 1 |
| He, JC; Pu, ZP; Xia, JM; Xie, W | 1 |
| Grady, JJ; Manning, KJ; Steffens, DC; Wu, R | 1 |
| Dmitrzak-Weglarz, M; Kapelski, P; Narozna, B; Pawlak, J; Rajewska-Rager, A; Skibinska, M; Szczepankiewicz, A; Twarowska-Hauser, J | 1 |
| Binder, EB; Carrillo-Roa, T; Craighead, WE; Debattista, C; Dunlop, BW; Goldstein-Piekarski, AN; Mayberg, HS; Nemeroff, CB; O'Connell, CP; Schatzberg, AF; Williams, LM | 1 |
| Katsanos, AH; Paraschakis, A | 1 |
| Allgaier, AK; Coyne, JC; Hautzinger, M; Hegerl, U; Henkel, V; Mergl, R | 1 |
| Alvarez-Ricartes, N; Barreto, GE; Echeverria, F; Echeverria, V; Iarkov, A; Mendoza, C; Oliveros-Matus, P; Perez-Urrutia, N | 1 |
| Kobayashi, N; Takano, M | 1 |
| Beyer, JL; Johnson, KG | 1 |
| Bussel, N; Chen, ST; Narvaez, T; Sultzer, DL; Weissberger, GH; Yarns, BC | 1 |
| Chen, D; Feng, X; Li, T; Li, X; Liu, X; Sun, M; Xu, J; Zhang, Q; Zhang, S; Zhao, X | 1 |
| Andersson, E; Bergmark, M; Blennow, M; Blomdahl-Wetterholm, M; Forsberg, L; Forsell, E; Forsgren, A; Frööjd, S; Goldman, A; Gustafsson, LL; Heinonen, E; Kaldo, V; Nasiell, J; Nordenadler, EM; Sklivanioti, M; Szymanska-von Schultz, B; Wide, K | 1 |
| Artigas, F; Bortolozzi, A; Ferrés-Coy, A; Fullana, MN; Meana, JJ; Ortega, JE; Paz, V; Ruiz-Bronchal, E | 1 |
| Augustin, M; Franz, C; Gründer, G; Paulzen, M; Saßmannshausen, H; Schoretsanitis, G | 1 |
| Gotlib, IH; Kircanski, K; Williams, LM | 1 |
| Chang, L; Chen, J; Hashimoto, K; Ishima, T; Ma, M; Pu, Y; Ren, Q; Xiong, Z; Zhang, K | 1 |
| Barbui, C; Caruso, R; Gastaldon, C; Grassi, L; Hotopf, M; Ostuzzi, G; Papola, D; Rayner, L; Turrini, G | 1 |
| Cheng, JH; Jiang, T; Jin, L; Jin, XJ; Lu, Y; Ma, J; Piao, HN; Piao, LX; Xu, X; Zhao, XD | 1 |
| Chen, Z; Feng, R; Fu, B; Gao, C; Jiao, J; Li, L; Li, M; Wang, P; Wang, S; Yang, J; Yang, Y; Zhang, Z | 1 |
| Chen, ZY; Feng, B; Ge, N; Luo, LY; Ning, F; Qian, MC; Tan, QR; Wang, HN; Wu, JY; Yang, SJ; Zhang, N; Zhang, Y; Zhang, ZJ; Zheng, ZL; Zhu, RM | 1 |
| Carson-Chahhoud, KV; Pollok, J; van Agteren, JE | 1 |
| Bassi, M; Cauli, G; Gala, C; Iapichino, E; Marconi, AM; Quartieri Bollani, M; Rucci, P | 1 |
| Coppola, E; Gaynes, BN; Henninger, ML; O'Connor, E; Senger, CA | 1 |
| Cohen, SD; Cukor, D; Dember, LM; Diaz-Linhart, Y; Dubovsky, A; Greene, T; Grote, N; Heagerty, P; Hedayati, SS; Kimmel, PL; Kutner, N; Mehrotra, R; Quinn, DK; Rue, T; Trivedi, MH; Unruh, M; Ver Halen, N; Weisbord, SD; Young, BA | 1 |
| Brummelte, S; Kott, JM; Mooney-Leber, SM | 1 |
| Assimon, MM; Brookhart, MA; Flythe, JE | 1 |
| Hollon, SD | 1 |
| Deng, XY; Xu, TS | 1 |
| Bai, ZF; Wang, LY | 1 |
| Anlacan, VMM; Espiritu, AI; Reyes, NGD | 1 |
| Banerjee, S; Chua, KC; Hellier, J; Voshaar, RO; Zuidersma, M | 1 |
| Akinbo, OI; Dagner, A; Grippo, AJ; Ihm, E; McNeal, N; Normann, MC; Wardwell, J; Watanasriyakul, WT | 1 |
| Almeida, OP | 1 |
| Bacon, F; Clarke, CS; Donkor, Y; Duffy, L; Freemantle, N; Gilbody, S; Hunter, R; Kendrick, T; Kessler, D; King, M; Lanham, P; Lewis, G; Mangin, D; Marston, L; Moore, M; Nazareth, I; Wiles, N | 1 |
| Baldwin, DS; Chen, X; Fu, J; Fu, T; Gao, Z; Hou, R; Liu, Q; Liu, Y; Pan, M; Tang, Z; Ye, G; Zhu, F | 1 |
| Dalsgaard, MK; Florea, I; Reines, EH; Saito, T | 1 |
| Eriksson, E; Hieronymus, F; Lisinski, A; Nilsson, S | 1 |
| Beiraghi, N; Hajifathali, A; Kazemi, MH; Mehdizadeh, M; Mehrpooya, M; Tavakoli Ardakani, M | 1 |
| Bies, RR; Drye, LT; Kirshner, M; Li, CH; Lyketsos, CG; Pollock, BG; Sorisio, D; Vaidya, V | 1 |
| Baldwin, R; Ballard, C; Banerjee, S; Bentham, P; Burns, A; Dewey, M; Fox, C; Hellier, J; Holmes, C; Katona, C; Knapp, M; Lawton, C; Lindesay, J; Livingston, G; McCrae, N; Moniz-Cook, E; Murray, J; Nurock, S; O'Brien, J; Orrell, M; Poppe, M; Romeo, R; Thomas, A; Walwyn, R; Wilson, K | 1 |
| Kaplan, C; Zhang, Y | 1 |
| Balasubramani, GK; Daly, E; Gaynes, BN; Kurian, BT; Lesser, I; Morris, DW; Nierenberg, AA; Rush, AJ; Trivedi, MH; Wisniewski, SR | 1 |
| Hult Lundh, S; Kirik, D; Nilsson, N; Petersén, Å; Soylu, R | 1 |
| Bussing, R; Geffken, GR; Mason, DM; McNamara, JP; Meyer, JM; Murphy, TK; Reid, AM; Storch, EA | 1 |
| Bharadwaj, B; Das, S; Patra, AP; Rayamane, AP; Shaha, KK; Tripathi, CS | 1 |
| Arnulf, I; Hao, Y; Jia, F; Li, X; Liu, W; Tang, Y; Zhang, B | 1 |
| Bhogle, M; Holland, J | 1 |
| Benseñor, IM; Brunoni, AR; Fregni, F; Júnior, RF; Kemp, AH; Lotufo, PA | 1 |
| Boyapati, R; Dev, A; Simpson, I; Suen, CF | 1 |
| Akhonzadeh, S; Dashti-Khavidaki, S; Ghaeli, P; Khatami, MR; Noorbala, AA; Taraz, M; Taraz, S | 1 |
| De La Haye, W; Gibson, RC; Henryl, M; Irons, A; Lowe, GA; Morgan, KA | 1 |
| Drye, LT; Flynn Longmire, CV; Frangakis, CE; Lyketsos, CG; Martin, BK; Meinert, CL; Mintzer, JE; Munro, CA; Porsteinsson, AP; Rabins, PV; Rosenberg, PB; Schneider, LS; Weintraub, D | 1 |
| Feeny, NC; Keller, SM; Zoellner, LA | 1 |
| Montgomery, SA; Reines, EH; Sanchez, C | 1 |
| Blumenthal, JA; Carney, RM; Combs, K; Craighead, WE; Freedland, K; Hoffman, B; Sherwood, A; Smith, PJ | 1 |
| Groban, L; Kitzman, DW; Register, TC; Shively, CA | 1 |
| Damkier, P; Hallas, J; Pottegård, A; Zoëga, H | 1 |
| Grzesiak, M; Pacan, P; Reich, A; Szepietowski, JC | 1 |
| Cargile, C; Chopra, MP; Guise, JB; Kosten, TR; Mancino, MJ; McGaugh, J; Oliveto, A; Sanders, N; Thostenson, J; Williams, DK | 1 |
| El-Amin, CK; Shively, CA; Silverstein, MG | 1 |
| Dai, ZY; Li, DQ; Li, XJ; Yang, WF; Zhen, JP; Zhu, BY | 1 |
| Ismailoglu, S; Kaygisiz, B; Kilic, FS; Oner, S | 1 |
| Gangadhar, S; Praharaj, SK; Sarkar, S; Subramaniam, E | 1 |
| Feeny, NC; Rosoff, CB; Rytwinski, NK; Zoellner, LA | 1 |
| Chengfeng, S; Lei, W; Lingjia, Q; Rui, Z; Wei, L; Xinxing, W | 1 |
| He, Y; Wan, Y; Wang, Z; Xu, C; Yang, H; Zheng, D; Zheng, Y; Zhou, L; Zhu, J | 1 |
| Furukawa, TA | 1 |
| Hu, J; Liu, J; Liu, Z; Rong, X; Wang, L; Xiao, S; Zhong, Z | 1 |
| Amminger, PG; Bonomally, R; Christensen, HM; Cockayne, NL; Duffy, SL; English, A; Hickie, IB; Mackinnon, A; Naismith, SL | 1 |
| Martins, V; Moreira, C; Oliveira, R | 1 |
| Alvarado, G; Artigas, F; Bortolozzi, A; Campa, L; Caso, JR; Ferrés-Coy, A; Galofré, M; Leza, JC; Montefeltro, A; Paz, V; Pazos, Á; Pilar-Cuéllar, F; Ruiz-Bronchal, E; Valdizán, EM; Vidal, R | 1 |
| Altemus, M; Gueorguieva, R; Kornstein, SG; Merry, B; Van Steenburgh, K; Yonkers, KA | 1 |
| Antoniazzi, CT; Barcelos, RC; Burger, ME; Duarte, MM; Duarte, T; Freitas, D; Metz, VG; Segat, HJ; Vey, LT | 1 |
| Azrael, D; Bushnell, GA; Miller, M; Pate, V; Stürmer, T; Swanson, SA; White, A | 1 |
| Cohen, S; Comstock, B; Cukor, D; Daniel, DM; Dember, LM; Diaz-Linhart, Y; Dubovsky, A; Greene, T; Grote, N; Heagerty, P; Hedayati, SS; Katon, W; Kimmel, PL; Kutner, N; Linke, L; Mehrotra, R; Quinn, D; Rue, T; Trivedi, MH; Unruh, M; Weisbord, S; Young, BA | 1 |
| Arns, M; Boutros, NN; Gordon, E | 1 |
| Chang, YD; Davis, MP; Gutgsell, T; Smith, J | 1 |
| Appt, SE; Carr, JJ; Clarkson, TB; Jones, SR; Kritchevsky, SB; Register, TC; Shively, CA; Silverstein-Metzler, MG | 1 |
| Echeverría, GA; Escudero, GE; Ferrer, EG; Laino, CH; López Tévez, LL; Martínez Medina, JJ; Martini, N; Piro, OE; Rodríguez, AN; Williams, PA | 1 |
| Etkin, A; Gyurak, A; Harris, A; Shilyansky, C; Usherwood, T; Williams, LM | 1 |
| Bagmetova, VV; Chernysheva, YV; Ozerov, AA; Tyurenkov, IN | 1 |
| Chang, LR; Chen, IM; Chen, TT; Huang, WL; Kuo, TB; Liao, SC; Yang, CC | 1 |
| Chen, XG; Li, HC; Li, QB; Tian, X; Wang, Y; Yang, XQ; Yang, YL; Zhu, H | 1 |
| Ahmed, S; Ghosh, P; Jangra, A; Khanam, R; Kumar, V; Kwatra, M; Mishra, M; Sharma, Y; Vohora, D | 1 |
| Craig, JC; Natale, P; Palmer, SC; Rabindranath, KS; Ruospo, M; Saglimbene, VM; Strippoli, GF | 1 |
| Bech, P; Carlsson, J; Elklit, A; Mortensen, EL; Sonne, C | 1 |
| De Agustín Sierra, L; García Díaz, B; Hidalgo Correas, FJ; Puebla Villaescusa, A; Ramírez Cruz, S; Salcedo Mingoarranz, AL | 1 |
| Bhattarai, M; Black, E; Nepal, H | 1 |
| Masiran, R; Pang, NT | 1 |
| Chen, J; Deng, X; Fang, L; Lei, T; Lei, Y; Qu, Z; Zhang, L; Zhao, X; Zhong, J; Zhou, C; Zou, B | 1 |
| Almond, M; Chilcot, J; Davenport, A; Day, C; Farrington, K; Friedli, K; Guirguis, A; Wellsted, D | 1 |
| Bah, TM; Boucher, M; Dufort, AM; Godbout, R; Kaloustian, S; Le Marec, N; Rousseau, G; Wann, BP | 1 |
| García-Sánchez, C; Gironell, A; Kulisevsky, J; Martínez-Corral, M; Pagonabarraga, J; Pascual-Sedano, B | 1 |
| Craft, RM; Cunningham, KA; Seitz, PK; Sell, SL; Stutz, SJ; Thomas, ML | 1 |
| Aksoz, E; Aksoz, T; Bilge, SS; Celik, S; Diren, HB; Ilkaya, F | 1 |
| Arias, RM; Callwood, DD; Cuffe, MS; Henke, E; Jiang, W; Krishnan, R; Kuchibhatla, M; O'Connor, C; Silva, SG; Zakhary, B | 1 |
| Olvey, EL; Skrepnek, GH | 1 |
| Antonini, A | 1 |
| Bootzin, E; Millan, MJ; O'Donnell, JM; Zhang, HT; Zhao, Z | 1 |
| Gunduz, F; Ozaras, R; Tabak, F; Tabak, O; Tahan, V | 1 |
| Ikonomidis, I; Kremastinos, DT; Lekakis, J; Moutsatsou, P; Nikolaou, M; Papoutsi, Z; Parissis, J | 1 |
| Coe, JW; Guanowsky, V; Mineur, YS; Picciotto, MR; Rollema, H; Seymour, PA; Shrikhande, A | 1 |
| Gopalakrishnan, R; O'Brien, C; Oslin, D; Ross, J | 1 |
| Abernethy, AP; Farrell, TW | 1 |
| Allgaier, AK; Coyne, J; Hautzinger, M; Hegerl, U; Henkel, V; Kohnen, R; Mergl, R; Scheunemann, W; Schütze, M | 1 |
| Barbui, C; Churchill, R; Cipriani, A; Furukawa, TA; La Ferla, T; McGuire, H; Nakagawa, A; Signoretti, A | 3 |
| Berger, M; Finkenzeller, W; Rietz, S; Schramm, E; Zobel, I | 1 |
| Bertram, L; Grözinger, M; Liss, Y | 1 |
| Arciniegas, DB; McAllister, TW; Silver, JM | 1 |
| De Fazio, P; De Fazio, S; De Sarro, G; Gareri, P; Segura-García, C | 1 |
| De Koning, FH; Derijks, HJ; Egberts, AC; Heerdink, ER; Janknegt, R; Krekels, MM; Looij, BJ | 1 |
| Angeloni, L; Costa, GM; Fontana, F; Mancini, S; Manzoli, L; Pizzi, C | 1 |
| Bonds, C; Davidson, MB; Duran, P; Echeverry, D; Lee, M | 1 |
| Baños, JH; Brunner, R; Meythaler, JM; Novack, TA; Renfroe, S | 1 |
| Atalay, H; Biyik, M; Biyik, Z; Guney, I; Solak, Y; Tonbul, HZ; Turk, S; Uguz, F; Yeksan, M | 1 |
| Adler, L; Amsterdam, J; Dunner, D; Feldman, P; Marchant, B; Michelson, D; Nierenberg, A; Reimherr, F; Schatzberg, A; Williams, D; Zhang, S | 1 |
| Endou, M; Kan, R; Unno, Y | 1 |
| Drye, LT; Frangakis, C; Lyketsos, CG; Martin, BK; Meinert, CL; Mintzer, JE; Munro, CA; Porsteinsson, AP; Rabins, PV; Rosenberg, PB; Schneider, LS; Weintraub, D | 2 |
| Gaur, V; Kumar, A | 1 |
| Baylé, FJ; Hajak, G; Hoogendijk, WJ; Kasper, S; Montejo, AL; Picarel-Blanchot, F; Quera-Salva, MA; Rybakowski, JK; Smeraldi, E; Wirz-Justice, AM; Wulff, K | 1 |
| Lo, V; Maggio, L | 1 |
| Douzenis, A; Flevari, P; Ikonomidis, I; Iliodromitis, E; Kremastinos, DT; Leftheriotis, D; Liapis, C; Lykouras, L; Paraskevaidis, I | 1 |
| Eksi Duran, N; Kocabay, G; Ozkan, M; Yildiz, M | 1 |
| Antonioli, L; Blandizzi, C; Colucci, R; Corona, T; Fornai, M; Mantarro, S; Montagnani, S; Pergola, A; Ruggiero, E; Scollo, C; Testi, A; Tuccori, M | 1 |
| Araneda, K; Berríos, C; Bravo, JA; Castañeda, P; Díaz-Veliz, G; Fiedler, JL; Menares, C; Mora, S; Morales, P; Ulloa, JL | 1 |
| Goodlin, SJ | 1 |
| Arias, RM; Callwood, DD; Cuffe, MS; Jiang, W; Krishnan, R; Kuchibhatla, M; O'Connor, CM; Rivelli, SK; Silva, SG; Stough, WG; Zakhary, B | 1 |
| Al-Jabi, SW; Awang, R; Sulaiman, SA; Zyoud, SH | 1 |
| Boyd, B; Krishnan, RR; Macfall, JR; Murali Doraiswamy, P; Payne, ME; Sheline, YI; Taylor, WD | 1 |
| Berlin, I; Chen, H; Covey, LS | 1 |
| Allnutt, SH; Butler, T; Carr, V; D'Este, C; Ellis, A; Greenberg, D; Indig, D; Knight, L; Mitchell, PB; Schofield, PW | 1 |
| Fischman, P; Miranda, M; Soto, F | 1 |
| Batra, P; Loyd, A; Patel, R; Stein, JA; Walters, R | 1 |
| Andreasen, JT; Bate, S; Christiansen, S; Henningsen, K; Wiborg, O | 1 |
| Birjandi, M; Jariani, M; Nazari, H; Saaki, M | 1 |
| Beran, J; Jankovec, Z; Komorousova, J; Rusavy, Z | 1 |
| Kodela, S; Venkata, PD | 1 |
| Barone, P | 1 |
| Ahmed, AH; Calvird, M; Gordon, RD; Pimenta, E; Stowasser, M; Taylor, PJ; Ward, G; Young, R | 1 |
| Arias, RM; Cuffe, MS; Jiang, W; Krishnan, R; Kuchibhatla, M; Martsberger, C; O'Connor, CM | 1 |
| Blazing, M; Blumenthal, JA; Bradley, L; Johnson, P; Keefe, FJ; Knowles, V; McKee, D; O'Connor, J; She, L; Shelby, RA; Silva, S; Somers, TJ; Varia, I; Waters, SJ | 1 |
| Kamijima, K; Sheehan, DV | 1 |
| Frith, AA; Hackshaw, A; MacGregor, EA | 1 |
| Brickman, AM; Garcon, E; Johnert, L; Muraskin, J; Provenzano, FA; Roose, SP; Sneed, JR; Yeung, LK; Zimmerman, ME | 1 |
| Gonsai, K; Gonzalez, G; Kosten, TR; Mancino, MJ; Oliveto, A; Poling, J; Pruzinsky, R; Sofuoglu, M; Thostenson, J; Tripathi, S; Williams, DK | 1 |
| Burke, HM; Epel, ES; Lerner, GK; Mellon, SH; Nelson, JC; Reus, VI; Rosser, R; Shelly, W; Wolf, J; Wolkowitz, OM | 1 |
| Chevarin, C; Du, X; Hannan, AJ; Lanfumey, L; Leang, L; Pang, TY; Renoir, T; Zajac, MS | 1 |
| Alvarado, G; Artigas, F; Bortolozzi, A; Carmona, MC; Castañé, A; Cortés, R; Fernández, G; Ferrés-Coy, A; Montefeltro, A; Perales, JC; Santana, N; Semakova, J; Toth, M | 1 |
| Andreadou, I; Antonellos, N; Douzenis, A; Ikonomidis, I; Kremastinos, D; Lykouras, E; Markantonis-Kiroudis, S; Michalakeas, CA; Nikolaou, M; Paraskevaidis, I; Parissis, JT; Varounis, C | 1 |
| Cao, BP; Dang, W; Fei, F; Hu, H; Hui, H; Jiang, XF; Li, J; Li, X; Qu, Y; Su, N; Wang, K; Zhang, L; Zhen, HN; Zhou, F | 1 |
| Chander, WP; Mukhiya, GK; Singh, N | 1 |
| Bisgaard, CF; Christensen, T; Wiborg, O | 1 |
| Fischer, CE; Herrmann, N; Jiang, D; Joy, J; Ringer, L; Schweizer, TA | 1 |
| Allgaier, AK; Hautzinger, M; Hegerl, U; Helmreich, I; Henkel, V; Mergl, R; Tadić, A; Wagner, S | 1 |
| Fillenbaum, GG; Kuchibhatla, MN | 1 |
| Allison, KC; Tarves, EP | 1 |
| Ikeda, K; Kobayashi, T; Washiyama, K | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Avramopoulos, D; Dimitri, A; Drye, LT; Frangakis, CE; Lyketsos, CG; Martin, BK; Meinert, CL; Mintzer, J; Munro, CA; Peters, ME; Porsteinsson, AP; Rabins, PV; Rosenberg, PB; Schneider, LS; Vaidya, V; Weintraub, D | 1 |
| Baydemir, C; Erol, K; Kaygisiz, B; Kilic, FS; Ozatik, Y | 1 |
| Erol, K; Ulupinar, E; Yildirim, E | 1 |
| Ikemoto, G; Mogi, T; Nomura, S; Yoshino, A | 1 |
| Barch, DM; Doraiswamy, PM; DʼAngelo, G; Garcia, KS; Gersing, K; Pieper, C; Sheline, YI; Taylor, W; Welsh-Bohmer, K; Wilkins, CH | 1 |
| Bušková, J; Piško, J; Sonka, K; Vorlová, T | 1 |
| Kitayama, S; Mamiya, T; Miyamoto, Y; Mouri, A; Nabeshima, T; Noda, Y; Sasaki, A; Sogawa, C; Watanabe, K; Yamada, K | 1 |
| Feltner, DE; Lenderking, WR; Mundt, JC; Vogel, AP | 1 |
| Garcia, CM; Mumby, PB; Stiff, PJ; Thilges, S | 1 |
| Dardis, C; Ly, V; Omoregie, E | 1 |
| Babyak, MA; Blumenthal, JA; Doraiswamy, PM; Hinderliter, AL; Hoffman, BM; Jiang, W; Johnson, J; Mabe, S; O'Hayer, CV; Schocken, DD; Sherwood, A; Smith, PJ; Watkins, LL | 1 |
| Baxter, L; Chen, K; Fort, C; Lane, RD; Smith, R | 1 |
| Bussing, R; Garvan, CW; Goodman, WK; McNamara, JP; Murphy, TK; Reid, AM; Storch, EA | 1 |
| Karaiskos, D; Paparrigopoulos, T; Spengos, K; Tzavellas, E; Vassilopoulou, S | 1 |
| Fiuzat, M; Jiang, W; Krishnan, R; Kuchibhatla, M; O'Connor, CM; Xiong, GL | 1 |
| Bak, S; Bisgaard, CF; Christensen, T; Enghild, JJ; Jensen, ON; Wiborg, O | 1 |
| Claxton, A; Hackett, ML; Hankey, GJ; Hsieh, CF; Kutlubaev, MA; Lee, R; Mead, GE | 1 |
| Kováru, F; Kovárů, H; Lisá, V | 1 |
| Nie, YX; Xu, TL | 1 |
| Maksimova, NM; Vertogradova, OP | 1 |
| Baldwin, R; Ballard, C; Banerjee, S; Bentham, P; Burns, A; Dewey, M; Fox, C; Hellier, J; Holmes, C; Katona, C; Knapp, M; Lawton, C; Lindesay, J; Livingston, G; McCrae, N; Moniz-Cook, E; Murray, J; Nurock, S; O'Brien, J; Poppe, M; Romeo, R; Thomas, A; Walwyn, R; Wilson, K | 1 |
| Kolesnikov, DB; Kotov, AM; Stotsky, AD | 1 |
| Denburg, JA; Lacosta, S; Sakic, B; Szechtman, H | 1 |
| Blanco, C; Garcia-Toro, M; Gonzalez, A; Gonzalez, E; Saiz-Ruiz, J; Talavera, JA; Tejada, P | 1 |
| Finkel, SI | 1 |
| Cooper, SJ; King, DJ; Lynch, G; Mulholland, C | 1 |
| Emes, R; Gill, T; Khouzam, HR; Raroque, R | 1 |
| Lacy, T; Mathis, M | 1 |
| Sansone, LA; Sansone, RA | 1 |
| Califf, RM; Finkel, MS; Gaffney, M; Glassman, AH; Harrison, W; Krishnan, KR; Malinin, AI; Musselman, DL; Nemeroff, CB; O'Connor, CM; Serebruany, VL; van Zyl, LT | 1 |
| Broocks, A; Hohagen, F; Kordon, A | 1 |
| Barton, D; Forman, LM; Gaffney, M; Glassman, AH; O'Connor, CM; Swedberg, K; Swenson, JR; Van Zyl, LT | 1 |
| Rosner, MH | 1 |
| Bassotti, G; de Roberto, G; Fischer, MJ; Morelli, A; Nzepa, FS | 1 |
| Waterfield, KE; Whipp, MJ | 1 |
| Eaddy, MT; Grudzinski, AN; McLaughlin, TP | 1 |
| de Oliveira Júnior, HP; Malbergier, A | 1 |
| Brooks, AC; Carpenter, KM; Nunes, EV; Vosburg, SK | 1 |
| Cryan, JF; Dalvi, A; Friedland, JC; Hirsch, BR; Jin, SH; Lucki, I; O'Leary, OF; Ouyang, M; Page, ME; Thomas, SA | 1 |
| Pergolizzi, JJ; Santos, RP | 1 |
| Barrera, M; Classen, C; Mohr, DC | 1 |
| Kumar, SN; Ramanathan, M; Suresh, B | 1 |
| Berigan, T | 2 |
| Reynolds, K | 1 |
| Curlin, D; Laizure, SC; Landy, S; McGinnis, J | 1 |
| Kim, JM; Kim, SW; Lee, H; Shin, IS; Yang, SJ; Yoon, JS | 1 |
| Fayyad, R; Gillespie, JA; Pearlstein, T; Yonkers, KA | 2 |
| Ros, LT | 3 |
| King, DA; Lyness, JM; Schum, JL | 1 |
| Anand, A; Bukhari, L; Gao, S; Kalnin, A; Li, Y; Lowe, MJ; Mathews, VP; Wang, Y; Wu, J | 1 |
| Harrison, D; Meng, F; Mullins, CD; Shaya, FT; Wang, J | 1 |
| Briley, KA; Goodale, ES; Gopal, KV; Hendea, OM | 1 |
| Alpsan-Omay, MH; Ceylan, ME | 1 |
| Holgers, KM; Svedlund, J; Zöger, S | 1 |
| Huber, A; Ling, W; Liu, J; Peck, J; Roll, J; Rotheram-Fuller, E; Shapiro, B; Shoptaw, S; Yang, X | 1 |
| Antonini, A; Barone, P; Canesi, M; De Gaspari, D; Mariani, C; Meucci, N; Pezzoli, G; Sacilotto, G; Tesei, S; Zecchinelli, A | 1 |
| Cummins, TK; Kratochvil, CJ; Martin, A; Varley, C | 1 |
| Bron, MS; Meng, F; Mullins, CD; Shaya, FT; Wang, J | 1 |
| Deas, D; Dosh, T; Kazura, A; Kratochvil, CJ; Martin, CA; Wilens, TE | 1 |
| Mago, R; Pinninti, NR | 1 |
| Lin, AN; Metelitsa, AI; Nguyen, GK | 1 |
| Bel'tikova, KV; Gorobets, LN; Kochetkov, IaA | 1 |
| Brenes, GA; Ip, E; Messier, SP; Pahor, M; Penninx, BW; Rejeski, WJ; Williamson, JD | 1 |
| Bach, M; Döing, C; Fürmaier, A; Normann, C; Schmitz, D | 1 |
| Kuczynski, E; Thomé-Souza, MS; Valente, KD | 1 |
| Getachew, Y; Handem, I; Jacobe, H; Mayo, MJ; Rush, AJ; Saldana, S | 1 |
| Ciechanowski, PS; Clouse, RE; Gelenberg, AJ; Hirsch, IB; Lustman, PJ; McGill, JB; Nix, BD; Rubin, EH; Sayuk, GS; Williams, MM | 1 |
| Goulia, P; Hyphantis, T; Mavreas, V; Pappas, D; Peritogiannis, V | 1 |
| Fountoulaki, K; Kremastinos, DT; Paraskevaidis, I; Parissis, J | 1 |
| Anand, A; Gardner, K; Li, Y; Lowe, MJ; Wang, Y | 1 |
| Bekele, NB; Shih, YC; Xu, Y | 1 |
| Babyak, MA; Blumenthal, JA; Doraiswamy, PM; Hinderliter, A; Hoffman, BM; Johnson, JJ; O'Connell, C; Patidar, SM; Rogers, SD; Sherwood, A; Watkins, L; Waugh, R | 1 |
| Agrawal, NK; Goyal, R; Rastogi, A; Singh, SK | 1 |
| Steptoe, A; Williams, ED | 1 |
| Al-Zaman, Y; Aylwin, S | 1 |
| Cherubini, A; Di Bari, M; Furneri, G; Lattanzio, F; Marchionni, N | 1 |
| Caswell, M; Flint, AJ; Heo, M; Meyers, BS; Mulsant, BH; Papademetriou, E; Peasley-Miklus, C; Rothschild, AJ; Smith, E | 1 |
| Koval'chuk, VV | 1 |
| Maksimova, NM; Misionzhnik, EIu; Uzbekov, MG; Vetrogradova, OP | 1 |
| Fawcett, JA; Gelenberg, A; Harrison, W; Hirschfeld, RM; Keller, MB; Klein, D; Kocsis, JH; McCullough, JP; Rush, AJ; Schatzberg, A | 1 |
| Christenson, JL; Cushing, AG; Haider, A; Miller, DR; Station, RD | 1 |
| Schleis, T | 1 |
| Iruela, LM | 1 |
| Berti, CA; Doogan, DP | 1 |
| Jackson, CW; Lydiard, RB; Morton, WA | 1 |
| Bandettini, FC; Bhatara, VS | 1 |
| Olanow, CW | 1 |
| Gammon, GD | 1 |
| Lane, RM; Preskorn, SH | 1 |
| Berti, C; Dinan, TG; Thakore, JH | 1 |
| Fattinger, K; Kind, B; Krähenbühl, S; Meier-Abt, PJ | 1 |
| Sprenger, D | 1 |
| Meier, E; Sánchez, C | 1 |
| Carson, WH; DeVane, CL; Gill, HS; Markowitz, JS | 1 |
| Feeney, DJ; Klykylo, WM | 1 |
| Noyer, CM; Schwartz, BM | 1 |
| Brown, C; Endicott, J; Frank, E; Freeman, E; Halbreich, U; Harrison, W; Parry, B; Pearlstein, T; Severino, S; Stone, A; Stout, A; Yonkers, KA | 1 |
| Hauser, RA; Zesiewicz, TA | 1 |
| Bundren, JC; Morris, DW; Warnock, JK | 2 |
| Bell, C; Nutt, DJ; Wilson, S | 1 |
| Bourin, M; Redrobe, JP | 1 |
| Roy, A | 1 |
| Bourgeois, JA; Johansen, T; Thomas, D; Walker, DM | 1 |
| Connor, TJ; Dredge, K; Harkin, A; Kelly, JP; Leonard, BE; McNamara, M; Redmond, A | 1 |
| Holman, RB; Nutt, DJ; Thomas, DN | 1 |
| Edgell, ET; Hylan, TR; Sacristán, JA | 1 |
| Meyers, BS | 1 |
| Jan, V; Lorette, G; Machet, L; Machet, MC; Toledano, C; Vaillant, L | 1 |
| Gattis, WA; Gurbel, PA; Murugesan, SR; Nair, GV; O'Connor, CM; Serebruany, VL | 1 |
| Donn, SM; Oca, MJ | 1 |
| Carrasco, JL; Díaz-Marsá, M; Sáiz-Ruiz, J | 1 |
| Azbel, V; Brenner, R; Madhusoodanan, S; Pawlowska, M | 1 |
| Ferreira, RC; Forlenza, OV; Hirata, ES; Stoppe Júnior, A | 1 |
| Buffum, J; Bui, BC; Chan, WK; Harralson, AF; Lee, AJ | 1 |
| Volicer, L | 1 |
| Boyer, P; Falissart, B; Tassin, JP; Troy, S | 1 |
| Audet, AM; Hartman, EE | 1 |
| Higuchi, T; Kamijima, K; Kiuchi, Y; Momose, K; Nara, K; Oguchi, K; Ozawa, H; Takahashi, K; Yamada, M; Yamada, S; Yamazaki, S | 1 |
| Cook, IA; Leuchter, AF | 1 |
| Brady, KT; McRae, AL | 1 |
| Hensley, PL; Reeve, A | 1 |
| Gurbel, PA; O'Connor, CM; Serebruany, VL | 1 |
| Boskailo, E; Djuric-Bijedic, Z; Lewis, J; Pavkovic, I; Smajkic, A; Weine, S | 1 |
| Engberg, R; Engberg, S; McDowell, BJ; Reynolds, CF; Sereika, S; Weber, E | 1 |
| Azadian, AG; Warnock, CA | 1 |
| Blakemore, KJ; Duhl, AJ; Escallon, CS; Nguyen, C | 1 |
| McTavish, D; Murdoch, D | 1 |
| Curtis, AL; Valentino, RJ | 1 |
| Guthrie, SK | 1 |
| Butler, J; Leonard, BE | 1 |
47 review(s) available for sertraline and Depression
| Article | Year |
|---|---|
Efficacy of Sertraline Combined with Cognitive Behavioral Therapy for Adolescent Depression: A Systematic Review and Meta-Analysis.
Topics: Adolescent; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Computational Biology; Depression; Female; Humans; Male; Psychology, Adolescent; Sertraline; Treatment Outcome | 2021 |
Short Term Second-Generation Antidepressant Monotherapy in Acute Depressive Episodes of Bipolar II Disorder: A Systematic Review and Meta-Analysis.
Topics: Antidepressive Agents, Second-Generation; Bipolar Disorder; Depression; Humans; Lithium; Randomized Controlled Trials as Topic; Sertraline; Venlafaxine Hydrochloride | 2022 |
Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Fluoxetine; Humans; Imipramine; Network Meta-Analysis; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2022 |
A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer's disease.
Topics: Alzheimer Disease; Depression; Escitalopram; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 2023 |
Selection of the optimal dose of sertraline for depression: A dose-response meta-analysis of randomized controlled trials.
Topics: Depression; Humans; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome | 2023 |
[Recent approaches to the diagnosis and therapy of monopolar depression].
Topics: Depression; Depressive Disorder; Humans; Psychometrics; Selective Serotonin Reuptake Inhibitors; Sertraline | 2023 |
Minor and subthreshold depressive disorders in Alzheimer's disease: A systematic review and meta-analysis of prevalence studies.
Topics: Alzheimer Disease; Depression; Depressive Disorder; Humans; Randomized Controlled Trials as Topic; Sertraline | 2020 |
Mood disorders and outcomes in lung cancer patients undergoing surgery: a brief summery.
Topics: Anxiety; Citalopram; Cognitive Behavioral Therapy; Combined Modality Therapy; Depression; Humans; Lung Neoplasms; Patient Care Team; Pneumonectomy; Postoperative Complications; Quality of Life; Randomized Controlled Trials as Topic; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide, Attempted; Survival Rate; Treatment Outcome | 2020 |
Efficacy of omega-3 supplementation on sertraline continuous therapy to reduce depression or anxiety symptoms: A systematic review and meta-analysis.
Topics: Adult; Anxiety; Coronary Disease; Depression; Dietary Supplements; Fatty Acids, Omega-3; Humans; Sertraline; Treatment Outcome | 2021 |
Efficacy of antidepressant drugs in the treatment of depression in Alzheimer disease patients: A systematic review and network meta-analysis.
Topics: Alzheimer Disease; Antidepressive Agents; Cognition; Depression; Humans; Mirtazapine; Network Meta-Analysis; Randomized Controlled Trials as Topic; Sertraline | 2021 |
What are the complications and emerging strategies for preventing depression following traumatic brain injury?
Topics: Brain Injuries, Traumatic; Depression; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 2017 |
Antidepressants for Depression Associated with Traumatic Brain Injury: A Meta-analytical Study of Randomised Controlled Trials.
Topics: Antidepressive Agents; Brain Injuries, Traumatic; Citalopram; Depression; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Treatment Outcome | 2017 |
Advances in Pharmacotherapy of Late-Life Depression.
Topics: Antidepressive Agents; Aripiprazole; Depression; Depressive Disorder; Drug Resistance; Duloxetine Hydrochloride; Humans; Paroxetine; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vortioxetine | 2018 |
Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis.
Topics: Adult; Antidepressive Agents; Citalopram; Depression; Humans; Myocardial Ischemia; Quality of Life; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome | 2019 |
Effect of sertraline in the treatment and prevention of poststroke depression: A meta-analysis.
Topics: Antidepressive Agents; Depression; Humans; Sertraline; Stroke | 2018 |
Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
Topics: Antidepressive Agents, Tricyclic; Depression; Dizziness; Dyspnea; Exercise Tolerance; Forced Expiratory Volume; Humans; Nausea; Nortriptyline; Paroxetine; Placebos; Pulmonary Disease, Chronic Obstructive; Quality of Life; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2018 |
Interventions to Prevent Perinatal Depression: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Topics: Antidepressive Agents; Behavior Therapy; Counseling; Depression; Depression, Postpartum; Female; Humans; Pregnancy; Pregnancy Complications; Referral and Consultation; Risk Factors; Sertraline | 2019 |
Efficacy of sertraline for post-stroke depression: A systematic review protocol of randomized controlled trial.
Topics: Antidepressive Agents; Depression; Humans; Randomized Controlled Trials as Topic; Sertraline; Stroke; Treatment Outcome | 2019 |
Efficacy of sertraline in post-traumatic brain injury (post-TBI) depression and quality of life: A systematic review and meta-analysis of randomized controlled trials.
Topics: Brain Injuries, Traumatic; Depression; Humans; Quality of Life; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome | 2019 |
Sertraline and mirtazapine as geriatric antidepressants.
Topics: Aged; Antidepressive Agents; Depression; Geriatric Psychiatry; Humans; Mianserin; Mirtazapine; Practice Guidelines as Topic; Sertraline | 2013 |
A comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?
Topics: Allosteric Site; Animals; Antidepressive Agents, Second-Generation; Citalopram; Depression; Depressive Disorder, Major; Drug Interactions; Evidence-Based Medicine; Humans; Models, Biological; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2014 |
Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis.
Topics: Adult; Antidepressive Agents; Citalopram; Depression; Fluoxetine; Humans; Kidney Failure, Chronic; Psychotherapy; Quality of Life; Randomized Controlled Trials as Topic; Renal Dialysis; Sertraline | 2016 |
Meta-analyses of comparative efficacy of antidepressant medications on peripheral BDNF concentration in patients with depression.
Topics: Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Clinical Trials as Topic; Data Interpretation, Statistical; Depression; Humans; Paroxetine; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Venlafaxine Hydrochloride | 2017 |
Pain and palliative care pharmacotherapy literature summaries and analyses.
Topics: Alzheimer Disease; Amphetamines; Anesthetics, Local; Anticoagulants; Antidepressive Agents; Depression; Donepezil; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Humans; Indans; Lidocaine; Nootropic Agents; Pain; Palliative Care; Phlebotomy; Piperidines; Prescription Drugs; Psychomotor Agitation; Randomized Controlled Trials as Topic; Sertraline; Stevens-Johnson Syndrome; Thromboembolism | 2009 |
Sertraline versus other antidepressive agents for depression.
Topics: Antidepressive Agents; Depression; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
Depression and cognitive complaints following mild traumatic brain injury.
Topics: Antidepressive Agents, Tricyclic; Brain; Brain Injuries; Central Nervous System Stimulants; Choline; Citalopram; Cognition Disorders; Cognitive Behavioral Therapy; Depression; Humans; Methylphenidate; Neuropsychological Tests; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2009 |
Sertraline versus other antidepressive agents for depression.
Topics: Antidepressive Agents; Depression; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Sertraline versus other antidepressive agents for depression.
Topics: Antidepressive Agents; Depression; Diarrhea; Humans; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
Topics: Abnormalities, Drug-Induced; Cardiovascular Abnormalities; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Maternal-Fetal Exchange; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Teratogens | 2010 |
Treatment of depressive symptoms in Parkinson's disease.
Topics: Antidepressive Agents, Tricyclic; Antiparkinson Agents; Benzothiazoles; Depression; Desipramine; Dopamine Agonists; Humans; Levodopa; Nortriptyline; Parkinson Disease; Pramipexole; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2011 |
An evidence-based review of the clinical use of sertraline in mood and anxiety disorders.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Anxiety Disorders; Child; Depression; Evidence-Based Medicine; Female; Humans; Male; Mood Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
Topics: Adult; Anxiety; Citalopram; Cognition; Depression; Fluoxetine; Humans; Nervous System Diseases; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stroke; Stroke Rehabilitation | 2012 |
[Antidepressants in cardiology].
Topics: Acetamides; Amitriptyline; Antidepressive Agents; Cardiovascular Diseases; Depression; Humans; Sertraline | 2012 |
Depression in the very old. Differences in presentation and approach to treatment: a case example.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Counseling; Depression; Drug Evaluation; Female; Follow-Up Studies; Geriatric Psychiatry; Humans; Male; Sertraline; Spouses; Treatment Outcome | 2003 |
The antidepressant sertraline: a review of its uses in a range of psychiatric and medical conditions.
Topics: Antidepressive Agents; Anxiety Disorders; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Fatigue Syndrome, Chronic; Feeding and Eating Disorders; Humans; Sertraline; Somatoform Disorders; Substance-Related Disorders | 2003 |
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Citalopram; Clomipramine; Depression; Diagnosis, Differential; Eczema; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Trichotillomania | 2003 |
Sertraline for the treatment of depression in coronary artery disease and heart failure.
Topics: Animals; Antidepressive Agents; Comorbidity; Coronary Artery Disease; Depression; Heart Failure; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2007 |
The role of depression in the etiology of acute coronary syndrome.
Topics: Acute Coronary Syndrome; Depression; Heart Rate; Humans; Prevalence; Selective Serotonin Reuptake Inhibitors; Sertraline | 2007 |
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide | 2008 |
Sertraline 50 mg daily: the optimal dose in the treatment of depression.
Topics: 1-Naphthylamine; Depression; Dose-Response Relationship, Drug; Humans; Safety; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
Depression and dementia: comorbidities, identification, and treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors.
Topics: Animals; Antidepressive Agents; Blood Platelets; Clinical Trials as Topic; Depression; Humans; Myocardial Infarction; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline | 1999 |
Tube feeding in Alzheimer's disease is avoidable.
Topics: Alzheimer Disease; Antidepressive Agents; Contraindications; Depression; Dronabinol; Eating; Enteral Nutrition; Humans; Psychotropic Drugs; Sertraline; Weight Loss | 1998 |
Review of sertraline and its clinical applications in psychiatric disorders.
Topics: Antidepressive Agents; Anxiety Disorders; Depression; Drug Interactions; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance-Related Disorders | 2001 |
Sertraline. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depression and obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Animals; Binding Sites; Brain; Depression; Drug Tolerance; Electroencephalography; Humans; Obsessive-Compulsive Disorder; Psychomotor Performance; Rats; Receptors, Neurotransmitter; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 1992 |
Pharmacology of locus coeruleus spontaneous and sensory-evoked activity.
Topics: 1-Naphthylamine; Action Potentials; Animals; Antidepressive Agents; Corticotropin-Releasing Hormone; Depression; Depression, Chemical; Desipramine; Drug Tolerance; Electroshock; Humans; Hypothalamo-Hypophyseal System; Locus Coeruleus; Mianserin; Nitroprusside; Pain; Rats; Sertraline; Stress, Physiological | 1991 |
Sertraline: a new specific serotonin reuptake blocker.
Topics: 1-Naphthylamine; Aged; Alcohol Drinking; Animals; Appetite; Clinical Trials as Topic; Depression; Down-Regulation; Drug Interactions; Humans; Middle Aged; Obsessive-Compulsive Disorder; Psychomotor Performance; Serotonin Antagonists; Sertraline | 1991 |
128 trial(s) available for sertraline and Depression
| Article | Year |
|---|---|
Comparative effectiveness of antidepressants on geriatric depression: Real-world evidence from a population-based study.
Topics: Aged; Antidepressive Agents; Citalopram; Depression; Escitalopram; Humans; Sertraline; Treatment Outcome | 2022 |
Predictors of relapse of psychotic depression: Findings from the STOP-PD II randomized clinical trial.
Topics: Antipsychotic Agents; Benzodiazepines; Chronic Disease; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Olanzapine; Sertraline; Treatment Outcome | 2023 |
Residual or re-emergent impaired insight into delusions following remission is unrelated to later relapse during a randomized clinical trial of continuation pharmacotherapy for psychotic depression - The STOP-PD II Study.
Topics: Antipsychotic Agents; Benzodiazepines; Delusions; Depression; Drug Therapy, Combination; Humans; Olanzapine; Psychotic Disorders; Sertraline; Treatment Outcome | 2023 |
Individualized fMRI connectivity defines signatures of antidepressant and placebo responses in major depression.
Topics: Antidepressive Agents; Brain; Depression; Depressive Disorder, Major; Double-Blind Method; Humans; Magnetic Resonance Imaging; Sertraline; Treatment Outcome | 2023 |
Antidepressants or running therapy: Comparing effects on mental and physical health in patients with depression and anxiety disorders.
Topics: Adult; Antidepressive Agents; Anxiety Disorders; Depression; Female; Hand Strength; Humans; Male; Sertraline | 2023 |
Genomic Investigation of Remission and Relapse of Psychotic Depression Treated with Sertraline plus Olanzapine: The STOP-PD II Study.
Topics: Antipsychotic Agents; Benzodiazepines; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Genomics; Humans; Male; Olanzapine; Sertraline; Treatment Outcome | 2023 |
The relationship of white matter microstructure with psychomotor disturbance and relapse in remitted psychotic depression.
Topics: Anisotropy; Brain; Depression; Depressive Disorder, Major; Humans; Psychotic Disorders; Sertraline; White Matter | 2023 |
Effects of Aphrodite (an Herbal Compound) on SSRI-Induced Sexual Dysfunctions and Depression in Females with Major Depressive Disorder: Findings from a Randomized Clinical Trial.
Topics: Adult; Depression; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological | 2023 |
Antidepressants for the prevention of depression following first-episode psychosis (ADEPP): study protocol for a multi-centre, double-blind, randomised controlled trial.
Topics: Adult; Antidepressive Agents; Child, Preschool; Depression; Humans; Infant; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Psychotic Disorders; Quality of Life; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome | 2023 |
Connectivity of the Cognitive Control Network During Response Inhibition as a Predictive and Response Biomarker in Major Depression: Evidence From a Randomized Clinical Trial.
Topics: Biomarkers; Cognition; Depression; Depressive Disorder, Major; Humans; Magnetic Resonance Imaging; Sertraline; Treatment Outcome | 2020 |
Effects of transcranial direct current stimulation using miniaturized devices vs sertraline for depression in Korea: A 6 week, multicenter, randomized, double blind, active-controlled study.
Topics: Depression; Depressive Disorder, Major; Double-Blind Method; Humans; Republic of Korea; Sertraline; Transcranial Direct Current Stimulation; Treatment Outcome | 2020 |
The Efficacy of Sertraline, Escitalopram, and Nicergoline in the Treatment of Depression and Apathy in Alzheimer's Disease: The Okayama Depression and Apathy Project (ODAP).
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Apathy; Citalopram; Depression; Female; Humans; Male; Nicergoline; Nootropic Agents; Prospective Studies; Sertraline; Single-Blind Method; Treatment Outcome | 2020 |
Can personalized treatment prediction improve the outcomes, compared with the group average approach, in a randomized trial? Developing and validating a multivariable prediction model in a pragmatic megatrial of acute treatment for major depression.
Topics: Antidepressive Agents; Depression; Depressive Disorder, Major; Humans; Precision Medicine; Sertraline; Treatment Outcome | 2020 |
The role of comorbid anxiety in exercise and depression trials: Secondary analysis of the SMILE-II randomized clinical trial.
Topics: Adult; Anxiety; Depression; Depressive Disorder, Major; Exercise; Humans; Sertraline; Treatment Outcome | 2021 |
Effect of Older vs Younger Age on Anthropometric and Metabolic Variables During Treatment of Psychotic Depression With Sertraline Plus Olanzapine: The STOP-PD II Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Depression; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Sertraline; Treatment Outcome; Young Adult | 2021 |
The effect of sertraline on emotional processing: secondary analyses of the PANDA randomised controlled trial.
Topics: Antidepressive Agents; Depression; Emotions; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 2022 |
[Effect of
Topics: Acupuncture Points; Acupuncture Therapy; Depression; Humans; Interleukin-2; Neoplasms; Sertraline; Treatment Outcome | 2021 |
Effect of sertraline on depression severity and prolactin levels in women with polycystic ovary syndrome: a placebo-controlled randomized trial.
Topics: Antidepressive Agents; Depression; Female; Humans; Patient Acuity; Polycystic Ovary Syndrome; Prolactin; Sertraline; Treatment Outcome | 2021 |
Reductions in guilt cognitions following prolonged exposure and/or sertraline predict subsequent improvements in PTSD and depression.
Topics: Cognition; Depression; Female; Guilt; Humans; Implosive Therapy; Male; Sertraline; Stress Disorders, Post-Traumatic; Treatment Outcome; Veterans | 2021 |
Physical exercise for late life depression: effects on cognition and disability.
Topics: Adult; Aged; Antidepressive Agents; Cognition; Depression; Disability Evaluation; Executive Function; Exercise; Exercise Therapy; Female; Humans; Italy; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Single-Blind Method | 2017 |
Do changes in trauma-related beliefs predict PTSD symptom improvement in prolonged exposure and sertraline?
Topics: Adult; Depression; Female; Humans; Implosive Therapy; Male; Middle Aged; Outcome Assessment, Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Thinking; Treatment Outcome | 2017 |
Effect of sertraline on complications and survival after hematopoietic stem-cell transplantation, a double-blind, placebo-controlled clinical study.
Topics: Adolescent; Adult; Allografts; Anxiety; Autografts; Depression; Disease-Free Survival; Double-Blind Method; Female; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Sertraline; Survival Rate | 2017 |
A randomised controlled trial assessing the severity and duration of depressive symptoms associated with a clinically significant response to sertraline versus placebo, in people presenting to primary care with depression (PANDA trial): study protocol for
Topics: Adolescent; Adult; Affect; Aged; Antidepressive Agents; Clinical Protocols; Depression; Double-Blind Method; England; Female; Humans; Male; Mental Health; Middle Aged; Patient Health Questionnaire; Quality of Life; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Time Factors; Treatment Outcome; Young Adult | 2017 |
Effect of Sertraline on Depressive Symptoms in Patients With Chronic Kidney Disease Without Dialysis Dependence: The CAST Randomized Clinical Trial.
Topics: Adult; Antidepressive Agents; Depression; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Middle Aged; Quality of Life; Renal Insufficiency, Chronic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2017 |
Antidepressant Outcomes Predicted by Genetic Variation in Corticotropin-Releasing Hormone Binding Protein.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Carrier Proteins; Citalopram; Depression; Female; Genotype; Homozygote; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2018 |
One-year follow-up of a randomized controlled trial of sertraline and cognitive behavior group therapy in depressed primary care patients (MIND study).
Topics: Adult; Antidepressive Agents; Cognitive Behavioral Therapy; Depression; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Primary Health Care; Psychotherapy, Group; Sertraline; Time Factors; Treatment Outcome | 2018 |
Sertraline for the Treatment of Depression in Vascular Cognitive Impairment.
Topics: Dementia, Vascular; Depression; Humans; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2018 |
MAGDALENA: study protocol of a randomised, placebo-controlled trial on cognitive development at 2 years of age in children exposed to SSRI in utero.
Topics: Child Development; Child, Preschool; Cognition; Cognitive Behavioral Therapy; Depression; Double-Blind Method; Female; Humans; Infant; Neurodevelopmental Disorders; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2018 |
Heart rate variability as a biomarker of anxious depression response to antidepressant medication.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Biomarkers; Citalopram; Depression; Depressive Disorder, Major; Female; Heart Rate; Humans; Male; Middle Aged; Prognosis; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2019 |
Transcutaneous electrical acupoint stimulation for post-traumatic stress disorder: Assessor-blinded, randomized controlled study.
Topics: Acupuncture Points; Adult; Cognitive Behavioral Therapy; Combined Modality Therapy; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Transcutaneous Electric Nerve Stimulation | 2019 |
Promoting the well-being of mothers with multidisciplinary psychosocial interventions in the perinatal period.
Topics: Adult; Antidepressive Agents; Anxiety; Combined Modality Therapy; Depression; Depression, Postpartum; Female; Humans; Longitudinal Studies; Mothers; Paroxetine; Patient Acceptance of Health Care; Perinatal Care; Pregnancy; Pregnancy Complications; Psychotherapy; Risk Factors; Sertraline; Treatment Outcome | 2019 |
Comparative Efficacy of Therapies for Treatment of Depression for Patients Undergoing Maintenance Hemodialysis: A Randomized Clinical Trial.
Topics: Adult; Antidepressive Agents; Cognitive Behavioral Therapy; Comparative Effectiveness Research; Depression; Female; Follow-Up Studies; Humans; Interview, Psychological; Kidney Failure, Chronic; Male; Middle Aged; Patient Acceptance of Health Care; Patient Compliance; Patient Reported Outcome Measures; Renal Dialysis; Sertraline | 2019 |
Comparing the Effectiveness of Depression Treatments for Patients Undergoing Maintenance Hemodialysis.
Topics: Antidepressive Agents; Cognitive Behavioral Therapy; Comparative Effectiveness Research; Depression; Follow-Up Studies; Humans; Interview, Psychological; Kidney Failure, Chronic; Patient Acceptance of Health Care; Patient Compliance; Patient Reported Outcome Measures; Renal Dialysis; Sertraline | 2019 |
[Clinical observation of acupuncture combined with sertraline hydrochloride tablets on tumor-related depression].
Topics: Acupuncture Therapy; Depression; Humans; Quality of Life; Sertraline; Tablets; Treatment Outcome | 2019 |
Sertraline and Mirtazapine Versus Placebo in Subgroups of Depression in Dementia: Findings From the HTA-SADD Randomized Controlled Trial.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Dementia; Depression; Double-Blind Method; England; Female; Humans; Male; Mirtazapine; Sertraline | 2019 |
A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRes
Topics: Adult; Aged; Antidepressive Agents; Citalopram; Cost-Benefit Analysis; Depression; Double-Blind Method; Fluoxetine; Humans; Middle Aged; Mirtazapine; Outcome Assessment, Health Care; Primary Health Care; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Sample Size; Sertraline | 2019 |
Sertraline treatment decreased the serum levels of interleukin-6 and high-sensitivity C-reactive protein in hematopoietic stem cell transplantation patients with depression; a randomized double-blind, placebo-controlled clinical trial.
Topics: C-Reactive Protein; Depression; Double-Blind Method; Hematopoietic Stem Cell Transplantation; Humans; Interleukin-6; Sertraline; Treatment Outcome | 2020 |
Population pharmacokinetic modeling of sertraline treatment in patients with Alzheimer disease: the DIADS-2 study.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Antidepressive Agents; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Models, Biological; Selective Serotonin Reuptake Inhibitors; Sertraline | 2013 |
Study of the use of antidepressants for depression in dementia: the HTA-SADD trial--a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine.
Topics: Aged; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cost-Benefit Analysis; Dementia; Depression; Double-Blind Method; Female; Humans; Male; Mianserin; Mirtazapine; Neuropsychological Tests; Psychiatric Status Rating Scales; Quality of Life; Sertraline; Surveys and Questionnaires; Treatment Outcome | 2013 |
Increase in work productivity of depressed individuals with improvement in depressive symptom severity.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depression; Drug Therapy, Combination; Efficiency; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Work; Young Adult | 2013 |
Prospective relationship between obsessive-compulsive and depressive symptoms during multimodal treatment in pediatric obsessive-compulsive disorder.
Topics: Adolescent; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Compulsive Behavior; Depression; Female; Humans; Male; Obsessive Behavior; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Symptom Assessment | 2014 |
Sertraline and rapid eye movement sleep without atonia: an 8-week, open-label study of depressed patients.
Topics: Adolescent; Adult; Antidepressive Agents; Cross-Sectional Studies; Depression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Polysomnography; Psychiatric Status Rating Scales; REM Sleep Behavior Disorder; Retrospective Studies; Sertraline; Time Factors; Video Recording; Young Adult | 2013 |
Differential improvement in depressive symptoms for tDCS alone and combined with pharmacotherapy: an exploratory analysis from the Sertraline vs. Electrical Current Therapy for Treating Depression Clinical Study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Combined Modality Therapy; Depression; Electric Stimulation Therapy; Female; Humans; Male; Middle Aged; Multivariate Analysis; Prefrontal Cortex; Psychiatric Status Rating Scales; Sertraline; Suicidal Ideation; Treatment Outcome; Young Adult | 2014 |
Sertraline decreases serum level of interleukin-6 (IL-6) in hemodialysis patients with depression: results of a randomized double-blind, placebo-controlled clinical trial.
Topics: Aged; Antidepressive Agents; Cytokines; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Renal Dialysis; Sertraline | 2013 |
Is sertraline treatment or depression remission in depressed Alzheimer patients associated with improved caregiver well being? Depression in Alzheimer's Disease Study 2.
Topics: Aged; Alzheimer Disease; Caregivers; Cost of Illness; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Remission, Spontaneous; Sertraline; Stress, Psychological | 2014 |
Impact of sleep complaints and depression outcomes among participants in the standard medical intervention and long-term exercise study of exercise and pharmacotherapy for depression.
Topics: Adult; Depression; Depressive Disorder, Major; Exercise Therapy; Female; Follow-Up Studies; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Treatment Outcome | 2014 |
Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms.
Topics: Adult; Amines; Cocaine-Related Disorders; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanecarboxylic Acids; Depression; Diagnosis, Dual (Psychiatry); Double-Blind Method; Drug Therapy, Combination; Female; GABA Agonists; Gabapentin; gamma-Aminobutyric Acid; Humans; Male; Medication Adherence; Patient Compliance; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2014 |
Effects of sertraline on executive function and quality of life in patients with advanced cancer.
Topics: Aged; Anxiety; Depression; Executive Function; Female; Humans; Male; Middle Aged; Neoplasms; Prospective Studies; Quality of Life; Regression Analysis; Sertraline | 2014 |
Are PTSD treatment choices and treatment beliefs related to depression symptoms and depression-relevant treatment rationales?
Topics: Adolescent; Adult; Aged; Choice Behavior; Combined Modality Therapy; Depression; Female; Health Knowledge, Attitudes, Practice; Humans; Implosive Therapy; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Young Adult | 2014 |
Sertraline hydrochloride treatment for patients with stable chronic obstructive pulmonary disease complicated with depression: a randomized controlled trial.
Topics: Aged; Antidepressive Agents; Case-Control Studies; Depression; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Pulmonary Disease, Chronic Obstructive; Quality of Life; Sertraline; Treatment Outcome | 2016 |
Sertraline plus deanxit to treat patients with depression and anxiety in chronic somatic diseases: a randomized controlled trial.
Topics: Aged; Anthracenes; Antidepressive Agents; Antipsychotic Agents; Anxiety; Chronic Disease; Depression; Drug Combinations; Drug Monitoring; Drug Therapy, Combination; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome | 2015 |
The Beyond Ageing Project Phase 2--a double-blind, selective prevention, randomised, placebo-controlled trial of omega-3 fatty acids and sertraline in an older age cohort at risk for depression: study protocol for a randomized controlled trial.
Topics: Age Factors; Aged; Aging; Antidepressive Agents; Clinical Protocols; Depression; Double-Blind Method; Drug Therapy, Combination; Fatty Acids, Omega-3; Female; Humans; Intention to Treat Analysis; Male; Middle Aged; Neuroimaging; New South Wales; Predictive Value of Tests; Proton Magnetic Resonance Spectroscopy; Psychiatric Status Rating Scales; Research Design; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Treatment Outcome | 2015 |
Symptom-Onset Dosing of Sertraline for the Treatment of Premenstrual Dysphoric Disorder: A Randomized Clinical Trial.
Topics: Adult; Anger; Depression; Double-Blind Method; Female; Humans; Irritable Mood; Luteal Phase; Premenstrual Dysphoric Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome | 2015 |
Rationale and design of A Trial of Sertraline vs. Cognitive Behavioral Therapy for End-stage Renal Disease Patients with Depression (ASCEND).
Topics: Antidepressive Agents; Cognitive Behavioral Therapy; Comorbidity; Depression; Depressive Disorder, Major; Dysthymic Disorder; Humans; Kidney Failure, Chronic; Renal Dialysis; Sertraline; Treatment Outcome | 2016 |
EEG Abnormalities Are Associated With Poorer Depressive Symptom Outcomes With Escitalopram and Venlafaxine-XR, but Not Sertraline: Results From the Multicenter Randomized iSPOT-D Study.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depression; Electroencephalography; Female; Humans; Internationality; Male; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2017 |
Effect of antidepressant treatment on cognitive impairments associated with depression: a randomised longitudinal study.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Citalopram; Cognitive Dysfunction; Depression; Female; Humans; Longitudinal Studies; Male; Middle Aged; Prospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2016 |
[Effect of Modified Guipi Decoction on Blood Pressure and Quality of Life in Hypertension Patients Complicated Depression].
Topics: Antidepressive Agents; Blood Pressure; Depression; Drugs, Chinese Herbal; Humans; Hypertension; Phytotherapy; Psychiatric Status Rating Scales; Quality of Life; Sertraline; Surveys and Questionnaires | 2016 |
Treatment of trauma-affected refugees with venlafaxine versus sertraline combined with psychotherapy - a randomised study.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Denmark; Depression; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Refugees; Research Design; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
Measuring Fatigue Using the Multidimensional Fatigue Inventory-20: A Questionable Factor Structure in Haemodialysis Patients.
Topics: Aged; Depression; Factor Analysis, Statistical; Fatigue; Female; Humans; Male; Middle Aged; Models, Statistical; Quality of Life; Renal Dialysis; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires | 2017 |
Motor changes during sertraline treatment in depressed patients with Parkinson's disease*.
Topics: Aged; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Cohort Studies; Depression; Depressive Disorder; Dopamine; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Prospective Studies; Quality of Life; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Severity of Illness Index | 2008 |
Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure.
Topics: Antidepressive Agents; Depression; Double-Blind Method; Heart Failure; Humans; Research Design; Sertraline | 2008 |
Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules.
Topics: Adult; Aged; Aorta; Cell Adhesion; Cell Survival; Chronic Disease; Citalopram; Depression; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Fluoxetine; Fluvoxamine; Heart Failure; Humans; Intercellular Adhesion Molecule-1; Middle Aged; Monocytes; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Tumor Necrosis Factor-alpha; U937 Cells; Vascular Cell Adhesion Molecule-1 | 2010 |
Course of late-life depression with alcoholism following combination therapy.
Topics: Aging; Alcoholism; Cognitive Behavioral Therapy; Combined Modality Therapy; Depression; Diagnosis, Dual (Psychiatry); Female; Humans; Male; Middle Aged; Naltrexone; Placebos; Sertraline; Severity of Illness Index; Treatment Outcome | 2009 |
Effects of pharmacotherapy and psychotherapy in depressed primary-care patients: a randomized, controlled trial including a patients' choice arm.
Topics: Adult; Antidepressive Agents; Cognitive Behavioral Therapy; Combined Modality Therapy; Depression; Female; Humans; Male; Middle Aged; Patient Dropouts; Patient Preference; Placebos; Psychiatric Status Rating Scales; Self-Help Groups; Sertraline; Treatment Outcome | 2010 |
[Interpersonal psychotherapy and pharmacotherapy for post-stroke depression. Feasibility and effectiveness].
Topics: Aged; Antidepressive Agents; Causality; Combined Modality Therapy; Comorbidity; Depression; Feasibility Studies; Female; Germany; Humans; Incidence; Interpersonal Relations; Male; Middle Aged; Psychotherapy; Sertraline; Stroke; Stroke Rehabilitation; Treatment Outcome | 2009 |
Effects of selective serotonin reuptake inhibitor therapy on endothelial function and inflammatory markers in patients with coronary heart disease.
Topics: Aged; C-Reactive Protein; Coronary Disease; Depression; Double-Blind Method; Endothelium, Vascular; Female; Follow-Up Studies; Humans; Inflammation; Interleukin-6; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Vasodilation | 2009 |
Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial.
Topics: Antidepressive Agents; Anxiety; Black People; Blood Pressure; Body Weight; Cholesterol, LDL; Depression; Diabetes Complications; Double-Blind Method; Female; Glycated Hemoglobin; Hispanic or Latino; Humans; Male; Placebos; Predictive Value of Tests; Quality of Life; Sertraline; Sexual Behavior; Surveys and Questionnaires | 2009 |
Impact of early administration of sertraline on depressive symptoms in the first year after traumatic brain injury.
Topics: Adult; Antidepressive Agents; Brain Injuries; Depression; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Sertraline | 2009 |
Genetic polymorphisms in the treatment of depression: speculations from an augmentation study using atomoxetine.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents; Atomoxetine Hydrochloride; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Gene Frequency; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Propylamines; Psychiatric Status Rating Scales; Serotonin Plasma Membrane Transport Proteins; Sertraline; Statistics, Nonparametric | 2010 |
Sertraline for the treatment of depression in Alzheimer disease.
Topics: Aged; Alzheimer Disease; Depression; Double-Blind Method; Female; Humans; Male; Medication Adherence; Patient Dropouts; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Efficacy of the novel antidepressant agomelatine on the circadian rest-activity cycle and depressive and anxiety symptoms in patients with major depressive disorder: a randomized, double-blind comparison with sertraline.
Topics: Acetamides; Actigraphy; Adolescent; Adult; Antidepressive Agents; Anxiety; Circadian Rhythm; Depression; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Middle Aged; Motor Activity; Psychiatric Status Rating Scales; Rest; Sertraline; Severity of Illness Index; Sleep; Treatment Outcome | 2010 |
Sertraline for the treatment of depression in Alzheimer disease: week-24 outcomes.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Antidepressive Agents; Cognition Disorders; Depression; Female; Geriatric Assessment; Humans; Male; Mental Disorders; Patient Compliance; Quality of Life; Sertraline | 2010 |
Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (Sertraline Against Depression and Heart Disease in Chronic Heart Failure) trial.
Topics: Aged; Antidepressive Agents; Chronic Disease; Depression; Female; Heart Failure; Humans; Male; Middle Aged; Sertraline | 2010 |
Depressive mood, suicide ideation and anxiety in smokers who do and smokers who do not manage to stop smoking after a target quit day.
Topics: Adolescent; Adult; Aged; Anxiety; Depression; Depressive Disorder, Major; Female; Humans; Linear Models; Male; Medical Records; Middle Aged; Patient Acceptance of Health Care; Placebos; Psychiatric Status Rating Scales; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Smoking; Smoking Cessation; Suicidal Ideation; Young Adult | 2010 |
Reducing impulsivity in repeat violent offenders: an open label trial of a selective serotonin reuptake inhibitor.
Topics: Adult; Aggression; Anger; Criminals; Depression; Humans; Impulsive Behavior; Irritable Mood; Male; Patient Compliance; Selective Serotonin Reuptake Inhibitors; Sertraline; Violence | 2010 |
The effect of Olanzapine and Sertraline on personality disorder in patients with methadone maintenance therapy.
Topics: Adult; Aggression; Analgesics, Opioid; Anxiety; Benzodiazepines; Borderline Personality Disorder; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Interpersonal Relations; Male; Methadone; Obsessive Behavior; Olanzapine; Sampling Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Somatoform Disorders; Surveys and Questionnaires; Treatment Outcome | 2010 |
Glycemic control improvement through treatment of depression using antidepressant drugs in patients with diabetes mellitus type 1.
Topics: Adult; Antidepressive Agents; Anxiety; Blood Glucose; Blood Pressure; Body Weight; Depression; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Insulin; Male; Sertraline; Treatment Outcome | 2010 |
Effects of two selective serotonin reuptake inhibitor antidepressants, sertraline and escitalopram, on aldosterone/renin ratio in normotensive depressed male patients.
Topics: Adult; Aldosterone; Antidepressive Agents; Blood Pressure; Citalopram; Depression; Humans; Hydrocortisone; Hyperaldosteronism; Male; Renin; Renin-Angiotensin System; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors | 2011 |
Effects of coping skills training and sertraline in patients with non-cardiac chest pain: a randomized controlled study.
Topics: Adaptation, Psychological; Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Anxiety; Behavior Therapy; Chest Pain; Depression; Female; Follow-Up Studies; Humans; Male; Middle Aged; Pain Measurement; Psychotherapeutic Processes; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Time Factors; Treatment Outcome; Young Adult | 2011 |
Efficacy, safety, and tolerability of sertraline on depressive symptoms in women with comorbid migraine: an open-label study.
Topics: Adult; Depression; Female; Humans; Middle Aged; Migraine Disorders; Pyrrolidines; Quality of Life; Selective Serotonin Reuptake Inhibitors; Self Report; Serotonin Receptor Agonists; Sertraline; Tryptamines | 2011 |
Quantitative approaches for assessment of white matter hyperintensities in elderly populations.
Topics: Aged; Aged, 80 and over; Aging; Antidepressive Agents; Brain; Brain Mapping; Depression; Double-Blind Method; Electronic Data Processing; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Fibers, Myelinated; Nortriptyline; Psychiatric Status Rating Scales; Sertraline | 2011 |
Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms.
Topics: Adolescent; Adult; Ambulatory Care; Cocaine-Related Disorders; Cognitive Behavioral Therapy; Depression; Double-Blind Method; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Time Factors; Young Adult | 2012 |
Serum BDNF levels before treatment predict SSRI response in depression.
Topics: Adult; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Citalopram; Cross-Over Studies; Depression; Depressive Disorder; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method; Treatment Outcome | 2011 |
Sensitivity to changes during antidepressant treatment: a comparison of unidimensional subscales of the Inventory of Depressive Symptomatology (IDS-C) and the Hamilton Depression Rating Scale (HAMD) in patients with mild major, minor or subsyndromal depre
Topics: Adult; Antidepressive Agents; Cognitive Behavioral Therapy; Depression; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Diagnostic Errors; Drug Monitoring; Female; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Psychological Tests; Sensitivity and Specificity; Sertraline; Treatment Outcome; Weights and Measures | 2012 |
Trajectory classes of depression in a randomized depression trial of heart failure patients: a reanalysis of the SADHART-CHF trial.
Topics: Aged; Antidepressive Agents; Chronic Disease; Depression; Double-Blind Method; Female; Follow-Up Studies; Heart Failure; Humans; Longitudinal Studies; Male; Middle Aged; Models, Statistical; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Sertraline; Time Factors; Treatment Outcome | 2011 |
Cognitive improvement following treatment in late-life depression: relationship to vascular risk and age of onset.
Topics: Age of Onset; Aged; Antidepressive Agents; Cognition Disorders; Depression; Executive Function; Female; Humans; Male; Memory; Mental Status Schedule; Sertraline; Severity of Illness Index; Treatment Outcome; Vascular Diseases | 2012 |
Vocal acoustic biomarkers of depression severity and treatment response.
Topics: Adult; Antidepressive Agents; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Regression Analysis; Retrospective Studies; Sertraline; Speech Acoustics; Speech Production Measurement; Time Factors; United States; Young Adult | 2012 |
Comparison of early quality of life outcomes in autologous and allogeneic transplant patients.
Topics: Antidepressive Agents; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Neoplasms; Quality of Life; Sertraline; Stem Cell Transplantation; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome | 2012 |
Exercise and pharmacological treatment of depressive symptoms in patients with coronary heart disease: results from the UPBEAT (Understanding the Prognostic Benefits of Exercise and Antidepressant Therapy) study.
Topics: Aged; Antidepressive Agents; Comprehension; Coronary Disease; Depression; Exercise; Exercise Therapy; Humans; Male; Middle Aged; Prognosis; Sertraline; Treatment Outcome | 2012 |
Psychometric properties of the Treatment-Emergent Activation and Suicidality Assessment Profile (TEASAP) in youth with OCD.
Topics: Adolescent; Anxiety; Checklist; Child; Child Behavior; Depression; Female; Humans; Male; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Psychometrics; Psychomotor Agitation; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicidal Ideation | 2013 |
Duloxetine versus citalopram and sertraline in the treatment of poststroke depression, anxiety, and fatigue.
Topics: Activities of Daily Living; Adult; Aged; Antidepressive Agents; Anxiety; Citalopram; Depression; Duloxetine Hydrochloride; Fatigue; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Sertraline; Stroke; Thiophenes; Time Factors; Treatment Outcome; Young Adult | 2012 |
Health status and depression remission in patients with chronic heart failure: patient-reported outcomes from the SADHART-CHF trial.
Topics: Aged; Antidepressive Agents; Chronic Disease; Comorbidity; Depression; Female; Health Status; Heart Failure; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Self Report; Sertraline; Surveys and Questionnaires; Treatment Outcome; Walking | 2012 |
Cost-effectiveness analyses for mirtazapine and sertraline in dementia: randomised controlled trial.
Topics: Antidepressive Agents; Caregivers; Cost-Benefit Analysis; Dementia; Depression; Health Care Costs; Health Services for the Aged; Humans; Intention to Treat Analysis; Mianserin; Mirtazapine; Outcome Assessment, Health Care; Placebos; Psychiatric Status Rating Scales; Quality of Life; Sertraline; Time Factors | 2013 |
A double-blind, placebo-controlled trial of sertraline for depressive symptoms in patients with stable, chronic schizophrenia.
Topics: Adolescent; Adult; Aged; Chronic Disease; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Outpatients; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2003 |
Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy.
Topics: Biomarkers; Blood Platelets; Coronary Disease; Depression; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2003 |
Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome.
Topics: Acute Disease; Analysis of Variance; Antidepressive Agents; Coronary Disease; Depression; Female; Humans; Male; Middle Aged; Quality of Life; Regression Analysis; Sertraline; Treatment Outcome | 2003 |
The effect of sertraline and environmental context on treating depression and illicit substance use among methadone maintained opiate dependent patients: a controlled clinical trial.
Topics: Adult; Depression; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Environment; Female; Humans; Illicit Drugs; Male; Methadone; Narcotics; Reinforcement, Psychology; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Abuse Detection; Substance-Related Disorders; Time Factors | 2004 |
The relationship between social support, depression and treatment for depression in people with multiple sclerosis.
Topics: Adult; Antidepressive Agents; Cognitive Behavioral Therapy; Depression; Female; Humans; Male; Middle Aged; Multiple Sclerosis; Psychiatric Status Rating Scales; Psychotherapy, Group; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Support; Treatment Outcome | 2004 |
Selective serotonin reuptake inhibitors for migraine prophylaxis.
Topics: Adult; Depression; Double-Blind Method; Female; Humans; Male; Medical Records; Migraine Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 1999 |
Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
Topics: Adult; Antidepressive Agents; Central Nervous System Stimulants; Cognition Disorders; Depression; Double-Blind Method; Female; Humans; Male; Methylphenidate; Patient Selection; Post-Concussion Syndrome; Prospective Studies; Psychiatric Status Rating Scales; Psychological Tests; Quality of Life; Sertraline; Sleep; Sleep Stages; Treatment Outcome | 2005 |
Pretreatment pattern of symptom expression in premenstrual dysphoric disorder.
Topics: Adult; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Individuality; Luteal Phase; Personality Inventory; Premenstrual Syndrome; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2005 |
Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
Topics: Adult; Antidepressive Agents; Cohort Studies; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follicular Phase; Follow-Up Studies; Humans; Luteal Phase; Premenstrual Syndrome; Sertraline; Single-Blind Method; Substance Withdrawal Syndrome; Treatment Outcome | 2005 |
Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study.
Topics: Adult; Affect; Antidepressive Agents; Brain; Brain Mapping; Case-Control Studies; Depression; Emotions; Facial Expression; Female; Humans; Image Processing, Computer-Assisted; Linear Models; Magnetic Resonance Imaging; Male; Neural Pathways; Oxygen; Photic Stimulation; Sertraline | 2005 |
Selective serotonin reuptake inhibitors treatment effects on auditory measures in depressed female subjects.
Topics: Acoustic Impedance Tests; Adult; Brain; Depression; Dichotic Listening Tests; Evoked Potentials, Auditory, Brain Stem; Female; Fluoxetine; Humans; Loudness Perception; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Speech Perception | 2005 |
The effects of sertraline on severe tinnitus suffering--a randomized, double-blind, placebo-controlled study.
Topics: Adult; Antidepressive Agents; Anxiety; Depression; Double-Blind Method; Female; Humans; Male; Placebos; Sertraline; Severity of Illness Index; Surveys and Questionnaires; Tinnitus; Treatment Outcome | 2006 |
Randomized, placebo-controlled trial of sertraline and contingency management for the treatment of methamphetamine dependence.
Topics: Adult; Continuity of Patient Care; Demography; Depression; Diagnostic and Statistical Manual of Mental Disorders; Disruptive, Impulse Control, and Conduct Disorders; Double-Blind Method; Drug Administration Schedule; Female; Humans; Length of Stay; Male; Methamphetamine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome; Substance-Related Disorders; Surveys and Questionnaires; Treatment Outcome | 2006 |
Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression: effect on quality of life.
Topics: Amitriptyline; Antidepressive Agents; Depression; Female; Humans; Male; Middle Aged; Parkinson Disease; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method | 2006 |
Treatment of minor depression in older adults: a pilot study comparing sertraline and exercise.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Depression; Exercise; Female; Humans; Male; Pilot Projects; Sertraline; Surveys and Questionnaires; United States | 2007 |
Long-term plasticity of visually evoked potentials in humans is altered in major depression.
Topics: Analysis of Variance; Antidepressive Agents; Depression; Electroencephalography; Evoked Potentials, Visual; Humans; Neural Inhibition; Neuronal Plasticity; Photic Stimulation; Reaction Time; Sertraline; Time Factors; Visual Cortex | 2007 |
Sertraline as a first-line treatment for cholestatic pruritus.
Topics: Antidepressive Agents; Cholestasis, Intrahepatic; Chronic Disease; Cross-Over Studies; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Pain Measurement; Pilot Projects; Prospective Studies; Pruritus; Sertraline; Treatment Outcome | 2007 |
Efficacy of sertraline in prevention of depression recurrence in older versus younger adults with diabetes.
Topics: Adult; Age Factors; Age of Onset; Aged; Antidepressive Agents; Depression; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; Male; Middle Aged; Placebos; Sertraline | 2007 |
Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: an FMRI study.
Topics: Adolescent; Adult; Analysis of Variance; Antidepressive Agents; Brain Mapping; Case-Control Studies; Depression; Emotions; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Limbic System; Magnetic Resonance Imaging; Middle Aged; Oxygen; Photic Stimulation; Sertraline | 2007 |
Understanding prognostic benefits of exercise and antidepressant therapy for persons with depression and heart disease: the UPBEAT study--rationale, design, and methodological issues.
Topics: Adult; Antidepressive Agents; Biomarkers; Depression; Endpoint Determination; Exercise; Female; Heart Diseases; Humans; Male; Placebos; Randomized Controlled Trials as Topic; Sertraline; United States | 2007 |
Weight gain during olanzapine treatment for psychotic depression: effects of dose and age.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antidepressive Agents; Benzodiazepines; Canada; Depression; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Olanzapine; Risk Factors; Sertraline; Treatment Outcome; United States; Weight Gain | 2008 |
[Pharmacologic correction of psycho-emotive disorders in the rehabilitation of patients after removal of brain tumors].
Topics: Adult; Alprazolam; Amitriptyline; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Brain Neoplasms; Depression; Doxepin; Emotions; Female; Humans; Male; Maprotiline; Middle Aged; Moclobemide; Mood Disorders; Neurosurgical Procedures; Nialamide; Sertraline; Thiazepines; Trazodone; Treatment Outcome | 2007 |
[Dynamics of biochemical parameters in patients with anxious depression treated with serotonergic antidepressants with different mechanisms of action].
Topics: Adolescent; Adult; Albumins; Analgesics; Antidepressive Agents, Tricyclic; Anxiety; Blood Platelets; Depression; Double-Blind Method; Female; Follow-Up Studies; Humans; Male; Middle Aged; Monoamine Oxidase; Selective Serotonin Reuptake Inhibitors; Sertraline; Thiazepines; Treatment Outcome | 2008 |
Treatment of chronic depression with sertraline or imipramine: preliminary blinded response rates and high rates of undertreatment in the community.
Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Aged; Chronic Disease; Depression; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
Clinical effect of converting antidepressant therapy from fluoxetine to sertraline.
Topics: 1-Naphthylamine; Ambulatory Care; Antidepressive Agents; Depression; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Sertraline; Single-Blind Method | 1995 |
Symptomatic improvement of premenstrual dysphoric disorder with sertraline treatment. A randomized controlled trial. Sertraline Premenstrual Dysphoric Collaborative Study Group.
Topics: 1-Naphthylamine; Adult; Analysis of Variance; Depression; Double-Blind Method; Efficiency; Female; Humans; Irritable Mood; Luteal Phase; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Social Adjustment | 1997 |
Sertraline for the treatment of depression in Parkinson's disease.
Topics: 1-Naphthylamine; Aged; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Depression; Drug Interactions; Drug Therapy, Combination; Humans; Parkinson Disease; Pilot Projects; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Severity of Illness Index; Treatment Outcome | 1997 |
[Chronic depression in the year 2000: therapeutic hopes. 10th World Congress for Psychiatry. Madrid, 24 August 1996].
Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Depression; Humans; Placebos; Sertraline | 1996 |
Sertraline in the treatment of depression associated with gonadotropin-releasing hormone agonist therapy.
Topics: 1-Naphthylamine; Adult; Affect; Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Depression; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Psychiatric Status Rating Scales; Retrospective Studies; Sertraline | 1998 |
Placebo-controlled study of sertraline in depressed recently abstinent alcoholics.
Topics: Adult; Alcoholism; Depression; Double-Blind Method; Female; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1998 |
Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Depression; Double-Blind Method; Female; Humans; Hypericum; Male; Middle Aged; Phytotherapy; Plant Extracts; Plants, Medicinal; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome | 2000 |
Antidepressant efficacy of sertraline and imipramine for the treatment of major depression in elderly outpatients.
Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Double-Blind Method; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Outpatients; Sertraline; Treatment Outcome | 2000 |
The effects of grapefruit juice on sertraline metabolism: an in vitro and in vivo study.
Topics: Administration, Oral; Aged; Beverages; Chromatography, High Pressure Liquid; Citrus; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depression; Female; Food-Drug Interactions; Humans; In Vitro Techniques; Male; Microsomes; Middle Aged; Mixed Function Oxygenases; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1999 |
Depressive mood symptoms associated with ovarian suppression.
Topics: Adult; Antidepressive Agents; Depression; Double-Blind Method; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Ovary; Prospective Studies; Psychiatric Status Rating Scales; Sertraline | 2000 |
Sertraline, paroxetine, and venlafaxine in refugee posttraumatic stress disorder with depression symptoms.
Topics: Adult; Cyclohexanols; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Refugees; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Treatment Outcome; Venlafaxine Hydrochloride | 2001 |
203 other study(ies) available for sertraline and Depression
| Article | Year |
|---|---|
The role of BDNF exon I region methylation in the treatment of depression with sertraline and its clinical diagnostic value.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Biomarkers; Brain-Derived Neurotrophic Factor; Case-Control Studies; Depression; DNA Methylation; Exons; Female; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; ROC Curve; Sertraline; Young Adult | 2021 |
Risk of hospitalized depression and intentional self-harm with brand and authorized generic sertraline.
Topics: Depression; Hospitalization; Humans; Retrospective Studies; Self-Injurious Behavior; Sertraline | 2022 |
New role of sertraline against Toxoplasma gondii-induced depression-like behaviours in mice.
Topics: Animals; Depression; Mice; Microglia; Sertraline; Toxoplasma; Toxoplasmosis | 2021 |
Does Sertraline Affect Hypothalamic Food Intake Peptides in the Rat Experimental Model of Chronic Mild Stress-Induced Depression?
Topics: Animals; Depression; Disease Models, Animal; Eating; Hypothalamus; Male; Models, Theoretical; Neural Stem Cells; Peptides; Rats; Rats, Wistar; Sertraline; Stress, Psychological; Swimming | 2022 |
Multi-dimensional relationships among dementia, depression and prescribed drugs in England and Wales hospitals.
Topics: Aged; Anticonvulsants; Antidepressive Agents; Antipsychotic Agents; Depression; Donepezil; Dothiepin; Frontotemporal Dementia; Hospitals; Humans; Lamotrigine; Memantine; Mirtazapine; NAD; Sertraline; Valproic Acid; Venlafaxine Hydrochloride; Wales | 2022 |
[Influence of successful psychopharmacotherapy of anxiety-depressive spectrum disorders on the severity of chronic fatigue in patients with rheumatoid arthritis].
Topics: Antidepressive Agents; Anxiety; Arthritis, Rheumatoid; Biological Products; Depression; Fatigue Syndrome, Chronic; Humans; Sertraline; Severity of Illness Index | 2021 |
[Successful psychopharmacotherapy of anxiety and depressive disorders improve functional limitations in patients with rheumatoid arthritis].
Topics: Antirheumatic Agents; Anxiety; Arthritis, Rheumatoid; Biological Products; Depression; Depressive Disorder; Female; Humans; Male; Middle Aged; Sertraline; Severity of Illness Index | 2022 |
Estimating the prevalence of depression using wastewater-based epidemiology: A case study in Qinghai Province, West China.
Topics: Antidepressive Agents; China; Depression; Paroxetine; Prevalence; Sertraline; Venlafaxine Hydrochloride; Wastewater; Water Pollutants, Chemical | 2023 |
Do sociodemographic and clinical factors affect the selection of initial antidepressant treatment for depression in older adults? Results from a nationwide descriptive study in Denmark.
Topics: Aged; Antidepressive Agents; Citalopram; Cross-Sectional Studies; Denmark; Depression; Escitalopram; Humans; Mirtazapine; Sertraline | 2023 |
Population Pharmacokinetic Modeling to Inform Sertraline Dosing Optimization in Patients with Depression.
Topics: Adult; Antidepressive Agents; Depression; Depressive Disorder, Major; Female; Humans; Male; Sertraline | 2023 |
Microbiome and tryptophan metabolomics analysis in adolescent depression: roles of the gut microbiota in the regulation of tryptophan-derived neurotransmitters and behaviors in human and mice.
Topics: Adolescent; Animals; Coleoptera; Depression; Gastrointestinal Microbiome; Humans; Kynurenine; Metabolomics; Mice; Microbiota; Quinolinic Acid; Serotonin; Sertraline; Tryptophan | 2023 |
The effect of mobile-based logotherapy on depression, suicidal ideation, and hopelessness in patients with major depressive disorder: a mixed-methods study.
Topics: Depression; Depressive Disorder, Major; Humans; Logotherapy; Sertraline; Suicidal Ideation | 2023 |
MicroRNA profiling identifies a novel compound with antidepressant properties.
Topics: Animals; Antidepressive Agents; Brain Injuries, Traumatic; Computational Biology; Depression; Disease Models, Animal; Estradiol; Fluoxetine; Gene Expression Regulation; Hippocampus; Humans; Imipramine; MicroRNAs; Rats; Sertraline; Sulfonamides; Thiazoles | 2019 |
Examining the antidepressant scattergun approach.
Topics: Antidepressive Agents; Depression; Double-Blind Method; Primary Health Care; Sertraline; Treatment Outcome | 2019 |
Impact of CYP2C19 genotype on sertraline exposure in 1200 Scandinavian patients.
Topics: Adult; Aged; Antidepressive Agents; Cytochrome P-450 CYP2C19; Depression; Female; Genotype; Humans; Male; Middle Aged; Norway; Retrospective Studies; Scandinavian and Nordic Countries; Selective Serotonin Reuptake Inhibitors; Sertraline | 2020 |
Serotonin Syndrome in an Adolescent Girl.
Topics: Adolescent; Depression; Female; Humans; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline; Suicide, Attempted | 2019 |
Sertraline in primary care: comments on the PANDA trial.
Topics: Depression; Double-Blind Method; Primary Health Care; Sertraline; Treatment Outcome | 2020 |
Sertraline in primary care: comments on the PANDA trial.
Topics: Depression; Double-Blind Method; Primary Health Care; Sertraline; Treatment Outcome | 2020 |
Sertraline in primary care: comments on the PANDA trial.
Topics: Depression; Double-Blind Method; Primary Health Care; Sertraline; Treatment Outcome | 2020 |
Sertraline in primary care: comments on the PANDA trial - Authors' reply.
Topics: Depression; Double-Blind Method; Primary Health Care; Sertraline; Treatment Outcome | 2020 |
Saffron vs sertraline for depression in the elderly.
Topics: Aged; Aged, 80 and over; Crocus; Depression; Depressive Disorder, Major; Double-Blind Method; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 2020 |
Multinational Investigation of Fracture Risk with Antidepressant Use by Class, Drug, and Indication.
Topics: Aged; Antidepressive Agents; Depression; Female; Fractures, Bone; Humans; Male; North America; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Taiwan; United Kingdom; Venlafaxine Hydrochloride | 2020 |
Selective Inhibition of the Serotonin Transporter in the Treatment of Depression: Sertraline, Fluoxetine and Citalopram.
Topics: Citalopram; Depression; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2020 |
Anticonvulsant effects of sertraline: a case report.
Topics: Adult; Anticonvulsants; Depression; Epilepsy; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2020 |
Metamizole but not ibuprofen reduces the plasma concentration of sertraline: Implications for the concurrent treatment of pain and depression/anxiety disorders.
Topics: Anxiety Disorders; Depression; Dipyrone; Humans; Ibuprofen; Pain, Postoperative; Selective Serotonin Reuptake Inhibitors; Sertraline | 2021 |
Brain estrogen alters the effects of the antidepressant sertraline in middle-aged female and male mice.
Topics: Animals; Antidepressive Agents; Aromatase; Behavior, Animal; Brain; Depression; Estrogens; Female; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neurotransmitter Agents; Sertraline | 2020 |
The possible immunoregulatory and anti-inflammatory effects of selective serotonin reuptake inhibitors in coronavirus disease patients.
Topics: Anti-Inflammatory Agents; Anticoagulants; Antidepressive Agents; Antioxidants; Antiviral Agents; COVID-19 Drug Treatment; Cytokines; Depression; Humans; Immune System; Inflammation; Lung; Models, Theoretical; Risk; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Stress, Psychological | 2020 |
Clinical efficacy of sertraline in the treatment of depression caused by Alzheimer disease: A protocol of systematic review.
Topics: Alzheimer Disease; Antidepressive Agents; Depression; Humans; Randomized Controlled Trials as Topic; Research Design; Sertraline; Systematic Reviews as Topic; Treatment Outcome | 2020 |
Regaining Control: Anxiety in Sickle Cell Disease.
Topics: Adolescent; Anemia, Sickle Cell; Antidepressive Agents; Antisickling Agents; Anxiety Disorders; Chronic Pain; Depression; Female; Humans; Hydroxyurea; Self-Injurious Behavior; Sertraline | 2020 |
Molecular imaging of beta-amyloid deposition in late-life depression.
Topics: Age Factors; Aged; Alzheimer Disease; Amyloid beta-Peptides; Antidepressive Agents, Second-Generation; Citalopram; Dementia; Depression; Female; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Imaging; Positron-Emission Tomography; Sertraline | 2021 |
TRPA1 involvement in depression- and anxiety-like behaviors in a progressive multiple sclerosis model in mice.
Topics: Animals; Antioxidants; Anxiety; Behavior, Animal; Depression; Encephalomyelitis, Autoimmune, Experimental; Female; Hindlimb Suspension; Hippocampus; Inflammation Mediators; Mice; Mice, Inbred C57BL; Multiple Sclerosis, Chronic Progressive; Oximes; Prefrontal Cortex; Selective Serotonin Reuptake Inhibitors; Sertraline; TRPA1 Cation Channel | 2021 |
The safety and efficacy of botulinum toxin A on the treatment of depression.
Topics: Antidepressive Agents; Botulinum Toxins, Type A; Depression; Double-Blind Method; Humans; Sertraline; Treatment Outcome | 2021 |
Frontocingulate cerebral blood flow and cerebrovascular reactivity associated with antidepressant response in late-life depression.
Topics: Adult; Aged; Aging; Antidepressive Agents; Depression; Female; Frontal Lobe; Gyrus Cinguli; Hemodynamics; Humans; Late Onset Disorders; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Sertraline; Spin Labels; Treatment Outcome | 2017 |
Long-term sertraline treatment and depression effects on carotid artery atherosclerosis in premenopausal female primates.
Topics: Animals; Carotid Artery Diseases; Carotid Artery, Common; Depression; Disease Models, Animal; Female; Hot Flashes; Humans; Longitudinal Studies; Macaca fascicularis; Premenopause; Primates; Random Allocation; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline | 2017 |
Relationships of depressive behavior and sertraline treatment with walking speed and activity in older female nonhuman primates.
Topics: Aged; Aging; Analysis of Variance; Animals; Antidepressive Agents; Depression; Disease Models, Animal; Female; Haplorhini; Humans; Random Allocation; Reference Values; Sertraline; Treatment Outcome; Walking Speed | 2017 |
[Exploring the clinical characters of Shugan Jieyu capsule through text mining].
Topics: Anxiety; Data Mining; Depression; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Fluoxetine; Humans; Paroxetine; Sertraline | 2017 |
Presence of neuroticism and antidepressant remission rates in late-life depression: results from the Neurobiology of Late-Life Depression (NBOLD) study.
Topics: Aged; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Drug Monitoring; Drug Resistance; Female; Humans; Late Onset Disorders; Male; Middle Aged; Neuroticism; Personality Inventory; Psychiatric Status Rating Scales; Remission Induction; Sertraline; Treatment Outcome | 2018 |
Brain-derived neurotrophic factor (BDNF) serum level in women with first-episode depression, correlation with clinical and metabolic parameters.
Topics: Adult; Biomarkers; Brain-Derived Neurotrophic Factor; Cross-Sectional Studies; Depression; Female; Humans; Longitudinal Studies; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2018 |
Intranasal Cotinine Plus Krill Oil Facilitates Fear Extinction, Decreases Depressive-Like Behavior, and Increases Hippocampal Calcineurin A Levels in Mice.
Topics: Administration, Intranasal; Animals; Behavior, Animal; Calcineurin; Conditioning, Psychological; Cotinine; Depression; Euphausiacea; Extinction, Psychological; Fear; Hippocampus; Mice, Inbred C57BL; Models, Biological; Oils; Sertraline | 2018 |
Aripiprazole-induced sleep-related eating disorder: a case report.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Depression; Drug Therapy, Combination; Humans; Male; Night Eating Syndrome; Sertraline; Sleep Wake Disorders | 2018 |
Reversal of reserpine-induced depression and cognitive disorder in zebrafish by sertraline and Traditional Chinese Medicine (TCM).
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Cognition Disorders; Depression; Drugs, Chinese Herbal; Locomotion; Medicine, Chinese Traditional; Reserpine; Selective Serotonin Reuptake Inhibitors; Sertraline; Zebrafish | 2018 |
Selective Knockdown of TASK3 Potassium Channel in Monoamine Neurons: a New Therapeutic Approach for Depression.
Topics: Administration, Intranasal; Animals; Antidepressive Agents; Behavior, Animal; Depression; Down-Regulation; Gene Knockdown Techniques; Male; Mice, Inbred C57BL; Neurons; Norepinephrine; Potassium Channels; Reboxetine; RNA, Small Interfering; Serotonergic Neurons; Serotonin; Sertraline | 2019 |
Antidepressants in breast milk; comparative analysis of excretion ratios.
Topics: Adult; Antidepressive Agents; Breast Feeding; Child Development; Citalopram; Depression; Female; Humans; Infant; Milk, Human; Pregnancy; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Young Adult | 2019 |
Lack of rapid antidepressant effects of Kir4.1 channel inhibitors in a chronic social defeat stress model: Comparison with (R)-ketamine.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Depressive Disorder; Disease Models, Animal; Hippocampus; Ketamine; Male; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Potassium Channels, Inwardly Rectifying; Quinacrine; Sertraline; Stress, Psychological | 2019 |
Sertraline ameliorates inflammation in CUMS mice and inhibits TNF-α-induced inflammation in microglia cells.
Topics: Animals; Anti-Inflammatory Agents; Antidepressive Agents; Cell Line; Depression; Disease Models, Animal; Humans; Inflammation Mediators; Male; Mice; Mice, Inbred C57BL; Microglia; NF-kappa B; Receptors, Tumor Necrosis Factor; Sertraline; Signal Transduction; Transaminases; Tumor Necrosis Factor-alpha | 2019 |
Developmental outcomes after gestational antidepressant treatment with sertraline and its discontinuation in an animal model of maternal depression.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Corticosterone; Depression; Depressive Disorder; Disease Models, Animal; Exploratory Behavior; Female; Male; Maternal Behavior; Postpartum Period; Pregnancy; Pregnancy Complications; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Stress, Psychological | 2019 |
Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Topics: Age Factors; Aged; Aged, 80 and over; Cardiac Conduction System Disease; Citalopram; Death, Sudden, Cardiac; Depression; Electrocardiography; Female; Fluoxetine; Fluvoxamine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peroxidase; Registries; Renal Dialysis; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States | 2019 |
Treatment of Depression Versus Treatment of PTSD.
Topics: Depression; Depressive Disorder; Humans; Sertraline; Stress Disorders, Post-Traumatic | 2019 |
The negative effects of social bond disruption are partially ameliorated by sertraline administration in prairie voles.
Topics: Animals; Arvicolinae; Autonomic Agents; Autonomic Nervous System; Brain; Depression; Heart Rate; Male; Pair Bond; Sertraline; Social Isolation; Stress, Psychological | 2019 |
The Challenge of Treating Depression in Dementia.
Topics: Dementia; Depression; Humans; Mirtazapine; Sertraline; Technology Assessment, Biomedical | 2019 |
Effects of SSRIs on peripheral inflammatory cytokines in patients with Generalized Anxiety Disorder.
Topics: Adult; Aged; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; C-Reactive Protein; Citalopram; Cohort Studies; Cytokines; Depression; Depressive Disorder; Female; Humans; Interleukin-12; Interleukin-6; Male; Middle Aged; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2019 |
Management of Depression in Adolescents in Japan.
Topics: Adolescent; Adolescent Psychiatry; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Child; Depression; Female; Fluvoxamine; Humans; Internet; Japan; Male; Practice Patterns, Physicians'; Psychiatry; Sertraline; Surveys and Questionnaires | 2019 |
Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis.
Topics: Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depression; Depressive Disorder, Major; Fluoxetine; Humans; Longitudinal Studies; Outcome Assessment, Health Care; Paroxetine; Placebos; Psychiatric Status Rating Scales; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2019 |
Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population.
Topics: Age Factors; Aged; Antidepressive Agents; Citalopram; Comparative Effectiveness Research; Depression; Health Expenditures; Humans; Insurance Claim Review; Medicare; Medication Adherence; Racial Groups; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States | 2012 |
Hypothalamic expression of mutant huntingtin contributes to the development of depressive-like behavior in the BAC transgenic mouse model of Huntington's disease.
Topics: Animals; Anxiety; Behavior, Animal; Depression; Disease Models, Animal; Female; Humans; Huntingtin Protein; Huntington Disease; Hypothalamus; Male; Mice; Mice, Transgenic; Nerve Tissue Proteins; Neuropeptide Y; Receptors, Tachykinin; Sertraline; Vesicular Monoamine Transport Proteins | 2013 |
Impulsive frotteurism: a case report.
Topics: Antidepressive Agents; Child; Depression; Disruptive, Impulse Control, and Conduct Disorders; Humans; Male; Paraphilic Disorders; Psychotherapy; Sertraline | 2013 |
Acute liver injury secondary to sertraline.
Topics: Adult; Antidepressive Agents; Biopsy; Chemical and Drug Induced Liver Injury; Depression; Diagnosis, Differential; Female; Humans; Liver; Pregnancy; Pregnancy Complications; Sertraline | 2013 |
Capgras syndrome presenting in an adolescent girl in the Caribbean.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Capgras Syndrome; Caribbean Region; Depression; Dibenzothiazepines; Dose-Response Relationship, Drug; Family Relations; Female; Humans; Neuropsychological Tests; Olanzapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Remission Induction; Sertraline; Suicidal Ideation; Treatment Outcome | 2013 |
Depression sudden gains and transient depression spikes during treatment for PTSD.
Topics: Aged; Antidepressive Agents; Depression; Female; Humans; Implosive Therapy; Male; Middle Aged; Psychiatric Status Rating Scales; Self Report; Sertraline; Severity of Illness Index; Social Support; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Symptom Assessment; Treatment Outcome | 2014 |
Effect of depression and sertraline treatment on cardiac function in female nonhuman primates.
Topics: Analysis of Variance; Animals; Atherosclerosis; Body Weights and Measures; Comorbidity; Depression; Diet; Disease Models, Animal; Echocardiography; Female; Heart; Heart Failure; Heart Rate; Humans; Hydroxyindoleacetic Acid; Macaca fascicularis; Male; Myocardium; Placebos; Random Allocation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Use of SSRIs among Danish children: a nationwide study.
Topics: Adolescent; Age Distribution; Antipsychotic Agents; Child; Child, Preschool; Citalopram; Denmark; Depression; Drug Prescriptions; Drug Utilization Review; Female; Humans; Incidence; Kaplan-Meier Estimate; Male; Prevalence; Registries; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Onychotillomania in the course of depression: a case report.
Topics: Antidepressive Agents; Depression; Humans; Male; Middle Aged; Nails; Psychiatric Status Rating Scales; Remission Induction; Self-Injurious Behavior; Sertraline; Treatment Outcome | 2014 |
Selective serotonin reuptake inhibitor and bleeding in a cynomolgus macaque (Macaca fascicularis).
Topics: Animals; Animals, Laboratory; Depression; Hemorrhage; Macaca fascicularis; Monkey Diseases; Selective Serotonin Reuptake Inhibitors; Sertraline; Thrombocytopenia | 2014 |
Effects of single and combined gabapentin use in elevated plus maze and forced swimming tests.
Topics: Amines; Amitriptyline; Animals; Anticonvulsants; Anxiety; Cyclohexanecarboxylic Acids; Depression; Diazepam; Drug Therapy, Combination; Female; Gabapentin; gamma-Aminobutyric Acid; Ketamine; Maze Learning; Rats; Rats, Sprague-Dawley; Sertraline; Swimming; Treatment Outcome | 2014 |
Seizure with sertraline: is there a risk?
Topics: Antidepressive Agents; Depression; Female; Humans; Seizures; Sertraline; Young Adult | 2014 |
Hyperhomocysteinemia is a result, rather than a cause, of depression under chronic stress.
Topics: Animals; Behavior, Animal; Betaine-Homocysteine S-Methyltransferase; Chronic Disease; Depression; Disease Models, Animal; Homocysteine; Hyperhomocysteinemia; Male; Methionine; Rats, Wistar; Recombinant Proteins; Sertraline; Stress, Psychological | 2014 |
Adverse effects of antidepressants during pregnancy.
Topics: Adult; Antidepressive Agents; Depression; Evidence-Based Medicine; Female; Humans; Physician-Patient Relations; Physician's Role; Pregnancy; Pregnancy Complications; Referral and Consultation; Risk Assessment; Sertraline | 2014 |
Psychogenic Cough: A Rare Cause of Chronic Cough.
Topics: Anti-Allergic Agents; Antidepressive Agents; Antitussive Agents; Bronchodilator Agents; Chronic Disease; Cognitive Behavioral Therapy; Combined Modality Therapy; Cough; Depression; Female; Humans; Middle Aged; Sertraline; Stress, Psychological | 2015 |
Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration.
Topics: Administration, Intranasal; Animals; Antidepressive Agents; Arabidopsis Proteins; Brain; Corticosterone; Depression; Disease Models, Animal; DNA, Antisense; Endocytosis; Exploratory Behavior; Fluoxetine; Gene Expression Regulation; Intramolecular Transferases; Male; Mice; Mice, Inbred C57BL; Neurons; Phosphopyruvate Hydratase; RNA, Small Interfering; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Time Factors | 2016 |
Neonatal tactile stimulation decreases depression-like and anxiety-like behaviors and potentiates sertraline action in young rats.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Anxiety; Corticosterone; Depression; Disease Models, Animal; Female; Hydrocortisone; Male; Maze Learning; Physical Stimulation; Pregnancy; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming; Touch | 2015 |
Dosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box Warning.
Topics: Adolescent; Adult; Antidepressive Agents; Child; Child, Preschool; Citalopram; Cohort Studies; Databases, Factual; Depression; Dose-Response Relationship, Drug; Drug Labeling; Drug Prescriptions; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Practice Guidelines as Topic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Suicide, Attempted; United States; United States Food and Drug Administration; Young Adult | 2016 |
Pseudobulbar Affect or Depression in Dementia?
Topics: Aged, 80 and over; Alzheimer Disease; Crying; Depression; Diagnosis, Differential; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Sertraline inhibits increases in body fat and carbohydrate dysregulation in adult female cynomolgus monkeys.
Topics: Adipose Tissue; Animals; Antidepressive Agents; Body Composition; Body Weight; Carbohydrate Metabolism; Depression; Drug Administration Schedule; Female; Insulin; Longitudinal Studies; Macaca fascicularis; Models, Animal; Random Allocation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Improving the antidepressant action and the bioavailability of sertraline by co-crystallization with coumarin 3-carboxylate. Structural determination.
Topics: Animals; Anti-Infective Agents; Antidepressive Agents; Biological Availability; Coumarins; Crystallization; Depression; Male; Motor Activity; Rats; Rats, Wistar; Sertraline; Swimming; X-Ray Diffraction | 2016 |
Comparison of the Efficiency of Adeprophen and Antidepressants of Various Groups on the Model of Reserpine-Induced Depression in Rats.
Topics: Adenine; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Imipramine; Male; Motor Activity; Paroxetine; Rats; Reserpine; Sertraline; Venlafaxine Hydrochloride | 2016 |
The Effects of Antidepressants and Quetiapine on Heart Rate Variability.
Topics: Adult; Aged; Antidepressive Agents; Anxiety; Depression; Female; Heart Rate; Humans; Linear Models; Male; Medically Unexplained Symptoms; Mianserin; Middle Aged; Mirtazapine; Psychiatric Status Rating Scales; Quetiapine Fumarate; Sertraline; Taiwan; Venlafaxine Hydrochloride | 2016 |
Naringin and Sertraline Ameliorate Doxorubicin-Induced Behavioral Deficits Through Modulation of Serotonin Level and Mitochondrial Complexes Protection Pathway in Rat Hippocampus.
Topics: Animals; Behavior, Animal; Corticosterone; Depression; Doxorubicin; Flavanones; Hippocampus; Male; Mitochondria; Neuroprotective Agents; Oxidative Stress; Rats, Wistar; Serotonin; Sertraline | 2016 |
[Lung infiltrates associated with sertraline administration].
Topics: Aged, 80 and over; Depression; Female; Humans; Lung Diseases; Respiration Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Self-Harm in Sertraline-Induced Akathisia.
Topics: Akathisia, Drug-Induced; Depression; Diagnosis, Differential; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline | 2016 |
Cognitive impairment and depressive symptoms coexisting in an elderly man.
Topics: Aged; Antidepressive Agents; Cognitive Dysfunction; Delusions; Dementia, Vascular; Depression; Humans; Male; Neuropsychological Tests; Risk Factors; Sertraline | 2017 |
Behavioural signs of depression and apoptosis in the limbic system following myocardial infarction: effects of sertraline.
Topics: Animals; Antidepressive Agents; Apoptosis; bcl-2-Associated X Protein; Behavior, Animal; Biomarkers; Caspase 3; Depression; DNA Fragmentation; Limbic System; Male; Myocardial Infarction; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Sertraline | 2009 |
Estradiol-sertraline synergy in ovariectomized rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Depression; Drug Evaluation, Preclinical; Drug Synergism; Estradiol; Female; Gene Expression; Hippocampus; Mesencephalon; Ovariectomy; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Sertraline; Vagina | 2008 |
Antidepressant-like effects of echo-planar magnetic resonance imaging in mice determined using the forced swimming test.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Depression; Desipramine; Disease Models, Animal; Echo-Planar Imaging; Immobility Response, Tonic; Male; Mice; Mice, Inbred BALB C; Motor Activity; Sertraline; Swimming; Time Factors | 2008 |
The cost-effectiveness of sertraline in the treatment of depression.
Topics: Cost-Benefit Analysis; Depression; Economics, Pharmaceutical; Humans; Patient Compliance; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2008 |
Unraveling depression in Parkinson's disease.
Topics: Antidepressive Agents; Benzothiazoles; Clinical Trials as Topic; Cohort Studies; Depression; Depressive Disorder; Dopamine; Dopamine Agonists; Drug Interactions; Humans; Multicenter Studies as Topic; Parkinson Disease; Pramipexole; Quality of Life; Serotonin; Sertraline | 2008 |
Association of changes in norepinephrine and serotonin transporter expression with the long-term behavioral effects of antidepressant drugs.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Cyclohexanols; Depression; Down-Regulation; Fenclonine; Male; Monoamine Oxidase Inhibitors; Morpholines; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Protein Synthesis Inhibitors; Protriptyline; Rats; Rats, Sprague-Dawley; Reboxetine; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Sertraline; Venlafaxine Hydrochloride | 2009 |
Sertraline hepatotoxicity: report of a case and review of the literature.
Topics: Adolescent; Chemical and Drug Induced Liver Injury; Depression; Humans; Liver; Liver Function Tests; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
Varenicline has antidepressant-like activity in the forced swim test and augments sertraline's effect.
Topics: Animals; Antidepressive Agents; Benzazepines; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Mice; Mice, Inbred C57BL; Mice, Inbred ICR; Nicotinic Agonists; Quinoxalines; Receptors, Nicotinic; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming; Varenicline | 2009 |
Neopterin and C-reactive protein in the course of Stevens-Johnson syndrome: report of a case.
Topics: Anticonvulsants; Antidepressive Agents, Tricyclic; Biopsy; C-Reactive Protein; Depression; Drug Therapy, Combination; Female; Humans; Lamotrigine; Mianserin; Middle Aged; Mirtazapine; Neopterin; Selective Serotonin Reuptake Inhibitors; Sertraline; Stevens-Johnson Syndrome; Triazines | 2009 |
Sertraline-induced rhabdomyolysis in an elderly patient with dementia and comorbidities.
Topics: Aged; Dementia, Vascular; Depression; Female; Humans; Rhabdomyolysis; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
Influence of antidepressant use on glycemic control in patients with diabetes mellitus: an open-label comparative study.
Topics: Adult; Aged; Antidepressive Agents; Biomarkers; Citalopram; Depression; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Treatment Outcome | 2009 |
Sertraline treatment is associated with an improvement in depression and health-related quality of life in chronic peritoneal dialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Depression; Female; Humans; Male; Middle Aged; Peritoneal Dialysis; Prevalence; Quality of Life; Sertraline; Young Adult | 2010 |
[A case of serotonin syndrome following minimum doses of sertraline].
Topics: Aged; Depression; Female; Humans; Serotonin Syndrome; Sertraline | 2009 |
Behavioral, biochemical and cellular correlates in the protective effect of sertraline against transient global ischemia induced behavioral despair: possible involvement of nitric oxide-cyclic guanosine monophosphate study pathway.
Topics: Adult; Animals; Antidepressive Agents; Behavior, Animal; Cell Respiration; Cyclic GMP; Depression; Disease Models, Animal; Enzyme Inhibitors; Humans; Ischemic Attack, Transient; Mice; Motor Activity; Neuroprotective Agents; Neuropsychological Tests; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Oxidative Stress; Random Allocation; Reperfusion Injury; Sertraline | 2010 |
Clinical inquiries. What's best when a patient doesn't respond to the maximum dose of an antidepressant?
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Bupropion; Cognitive Behavioral Therapy; Depression; Humans; Imipramine; Lithium; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Failure | 2010 |
[Clinical experiences with agomelatine. The inner ear has to be synchronized again].
Topics: Acetamides; Antidepressive Agents; Circadian Rhythm; Controlled Clinical Trials as Topic; Depression; Ear, Inner; Humans; Hypnotics and Sedatives; Melatonin; Nervous System Diseases; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Wake Disorders; Tranquilizing Agents | 2010 |
The role of the selective serotonin re-uptake inhibitor sertraline in nondepressive patients with chronic ischemic heart failure: a preliminary study.
Topics: Aged; Antidepressive Agents; Chronic Disease; Defibrillators, Implantable; Depression; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Quality of Life; Refractory Period, Electrophysiological; Selective Serotonin Reuptake Inhibitors; Sertraline; Tachycardia, Ventricular; Treatment Outcome; Ventricular Premature Complexes | 2010 |
Sinus arrest due to sertraline.
Topics: Antidepressive Agents; Depression; Electrocardiography; Electrocardiography, Ambulatory; Electrophysiologic Techniques, Cardiac; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Sinus Arrest, Cardiac | 2010 |
Comparison of the antidepressant sertraline on differential depression-like behaviors elicited by restraint stress and repeated corticosterone administration.
Topics: Adrenal Glands; Animals; Antidepressive Agents, Second-Generation; Anxiety; Avoidance Learning; Conditioning, Operant; Corticosterone; Depression; Male; Organ Size; Rats; Rats, Sprague-Dawley; Rats, Wistar; Restraint, Physical; Sertraline; Stress, Psychological; Swimming; Weight Gain | 2010 |
Sadness in heart failure: what is a clinician to do?
Topics: Antidepressive Agents; Depression; Heart Failure; Humans; Sertraline | 2010 |
A cross-sectional observation of the factors associated with deliberate self-poisoning with acetaminophen: impact of gender differences and psychiatric intervention.
Topics: Acetaminophen; Adolescent; Adult; Age Factors; Antidepressive Agents; Cross-Sectional Studies; Depression; Drug Overdose; Female; Humans; Incidence; Length of Stay; Life Change Events; Malaysia; Male; Mental Disorders; Middle Aged; Patient Education as Topic; Prevalence; Referral and Consultation; Retrospective Studies; Risk Factors; Sertraline; Sex Factors; Suicide, Attempted | 2010 |
One-year change in anterior cingulate cortex white matter microstructure: relationship with late-life depression outcomes.
Topics: Aged; Anisotropy; Antidepressive Agents; Brain; Clinical Trials as Topic; Depression; Diffusion Tensor Imaging; Female; Follow-Up Studies; Gyrus Cinguli; Humans; Male; Nerve Fibers, Myelinated; Psychiatric Status Rating Scales; Remission Induction; Sertraline | 2011 |
Forme fruste of neuroleptic malignant syndrome associated with the use of sertraline.
Topics: Aged; Depression; Female; Humans; Neuroleptic Malignant Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 2011 |
Eruptive collagenomas.
Topics: Abdomen; Adult; Antidepressive Agents; Collagen; Collagen Diseases; Depression; Female; Hamartoma; Humans; Nevus; Sertraline; Skin Neoplasms; Treatment Outcome | 2010 |
Nicotine reverses anhedonic-like response and cognitive impairment in the rat chronic mild stress model of depression: comparison with sertraline.
Topics: Anhedonia; Animals; Antidepressive Agents; Behavior, Animal; Cognition Disorders; Depression; Disease Models, Animal; Drug Therapy, Combination; Male; Nicotine; Nicotinic Agonists; Rats; Rats, Wistar; Sertraline; Stress, Psychological; Sucrose | 2011 |
Antidepressant induced apathy responsive to dose reduction.
Topics: Antidepressive Agents; Apathy; Depression; Dose-Response Relationship, Drug; Humans; Male; Middle Aged; Sertraline | 2010 |
Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study).
Topics: Aged; Antidepressive Agents; Chronic Disease; Controlled Clinical Trials as Topic; Depression; Female; Heart Failure; Humans; Inpatients; Male; Middle Aged; Personality Inventory; Prevalence; Psychiatric Status Rating Scales; Remission Induction; Research Design; Sertraline; Severity of Illness Index; Treatment Outcome | 2011 |
Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Behavior, Animal; Depression; Disease Models, Animal; Feeding Behavior; Female; Gene Expression Regulation; Huntington Disease; Hydroxyindoleacetic Acid; Hyperthermia, Induced; Male; Mice; Mutation; Raphe Nuclei; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serotonin; Sertraline; Sex Characteristics; Swimming | 2011 |
Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Administration, Intranasal; Animals; Antidepressive Agents; Autoreceptors; Depression; Disease Models, Animal; Drug Combinations; Drug Design; Fluoxetine; Hippocampus; Hypothermia; Infusions, Intraventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Prefrontal Cortex; Receptor, Serotonin, 5-HT1A; RNA, Small Interfering; Serotonergic Neurons; Sertraline | 2012 |
Effects of sertraline on circulating markers of oxidative stress in depressed patients with chronic heart failure: a pilot study.
Topics: Aged; Biomarkers; Cohort Studies; Depression; Female; Heart Failure; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Sertraline | 2011 |
The brain-derived neurotrophic factor is associated with alcohol dependence-related depression and antidepressant response.
Topics: Adult; Alcoholism; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Chi-Square Distribution; China; Depression; Female; Gene Frequency; Genetic Association Studies; Genotype; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Retrospective Studies; Sertraline; Surveys and Questionnaires | 2011 |
Serotonin syndrome in maintenance haemodialysis patients following sertraline treatment for depression.
Topics: Adult; Aged; Aged, 80 and over; Depression; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline | 2011 |
Biomarkers of anhedonic-like behavior, antidepressant drug refraction, and stress resilience in a rat model of depression.
Topics: Anhedonia; Animals; Biomarkers; Citalopram; Depression; Disease Models, Animal; Drug Resistance; Eating; Gene Expression Profiling; Hippocampus; Humans; Male; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress, Psychological; Sucrose | 2011 |
Determining the impact of dementia on antidepressant treatment response in older adults.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Dementia; Depression; Female; Follow-Up Studies; Humans; Male; Mental Status Schedule; Quality of Life; Sertraline; Time Factors; Treatment Outcome | 2011 |
Treatment of night eating syndrome.
Topics: Anorexia; Behavior Therapy; Circadian Rhythm; Cognitive Behavioral Therapy; Depression; Diet Records; Energy Intake; Feeding and Eating Disorders; Feeding Behavior; Female; Humans; Hyperphagia; Hypnotics and Sedatives; Phototherapy; Pyridines; Randomized Controlled Trials as Topic; Relaxation Therapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders; Syndrome; Treatment Outcome; Zolpidem | 2011 |
Inhibition of G protein-activated inwardly rectifying K+ channels by different classes of antidepressants.
Topics: Amoxapine; Animals; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Ethanol; Female; GTP-Binding Proteins; Humans; Mice; Oocytes; Potassium Channels; RNA, Messenger; Sertraline; Thiophenes; Xenopus laevis | 2011 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
Sertraline for the treatment of depression in Alzheimer disease: genetic influences.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Depression; Female; Genotype; Humans; Male; Middle Aged; Multicenter Studies as Topic; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2011 |
Acute antidepressant and anxiolytic effects of simvastatin and its mechanisms in rats.
Topics: Amitriptyline; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Depression; Drug Therapy, Combination; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Maze Learning; Motor Activity; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Simvastatin | 2012 |
Effects of sertraline on behavioral alterations caused by environmental enrichment and social isolation.
Topics: Animals; Antidepressive Agents; Anxiety; Depression; Environment; Female; Housing, Animal; Male; Maze Learning; Motor Activity; Rats; Rats, Wistar; Sertraline; Social Isolation; Treatment Outcome | 2012 |
Mirtazapine as an alternative for selective-serotonin-reuptake-inhibitor-induced syndrome of inappropriate secretion of antidiuretic hormone.
Topics: Aged; Antidepressive Agents, Tricyclic; Depression; Humans; Inappropriate ADH Syndrome; Male; Mianserin; Mirtazapine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2012 |
Severe sleep-related movement disorder induced by sertraline.
Topics: Depression; Humans; Male; Middle Aged; Nocturnal Myoclonus Syndrome; Restless Legs Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2012 |
MAGE-D1 regulates expression of depression-like behavior through serotonin transporter ubiquitylation.
Topics: Animals; Antidepressive Agents; Antigens, Neoplasm; Behavior, Animal; Brain; CHO Cells; Cricetinae; Depression; Female; Gene Knockdown Techniques; Imipramine; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microinjections; Neoplasm Proteins; Protein Binding; RNA, Small Interfering; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Ubiquitination | 2012 |
Fatal serotonin syndrome precipitated by oxcarbazepine in a patient using an selective serotonin reuptake inhibitor.
Topics: Aged, 80 and over; Analgesics; Antihypertensive Agents; Atrial Fibrillation; Bronchodilator Agents; Carbamazepine; Coronary Artery Disease; Depression; Diabetes Mellitus; Diabetic Neuropathies; Drug Interactions; Fatal Outcome; Humans; Hypertension; Hypoglycemic Agents; Male; Neuralgia; Oxcarbazepine; Pulmonary Disease, Chronic Obstructive; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline | 2012 |
Antidepressant effects of sertraline associated with volume increases in dorsolateral prefrontal cortex.
Topics: Adult; Antidepressive Agents; Case-Control Studies; Depression; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Prefrontal Cortex; Sertraline; Treatment Outcome | 2013 |
Vesicular signalling and immune modulation as hedonic fingerprints: proteomic profiling in the chronic mild stress depression model.
Topics: Anhedonia; Animals; Citalopram; Depression; Disease Models, Animal; Hippocampus; Immune System; Laser Capture Microdissection; Male; Protein Processing, Post-Translational; Proteins; Proteomics; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Signal Transduction; Stress, Psychological; Tandem Mass Spectrometry; Two-Dimensional Difference Gel Electrophoresis | 2012 |
Effect of fluoxetine and adenosine receptor NECA agonist on G alpha q/11 protein of C6 glioma cells.
Topics: Adenosine-5'-(N-ethylcarboxamide); Animals; Brain Neoplasms; Cell Line, Tumor; Citalopram; Depression; Fluoxetine; Glioma; GTP-Binding Protein alpha Subunits, Gq-G11; Neurons; Purinergic P1 Receptor Agonists; Rats; Selective Serotonin Reuptake Inhibitors; Sertraline; Signal Transduction | 2012 |
[Cognitive behavioral therapy for depression in advanced schistosomiasis patients].
Topics: Aged; Cognitive Behavioral Therapy; Combined Modality Therapy; Depression; Female; Humans; Male; Middle Aged; Schistosomiasis; Sertraline | 2012 |
[The dynamics of anxious depression under the treatment with antidepressants with different mechanisms of action].
Topics: Adolescent; Adult; Antidepressive Agents; Anxiety Disorders; Depression; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Selective Serotonin Reuptake Inhibitors; Sertraline; Thiazepines; Treatment Outcome; Young Adult | 2012 |
Altered neurotransmission in brains of autoimmune mice: pharmacological and neurochemical evidence.
Topics: Aging; Animals; Antibodies, Antinuclear; Autoimmune Diseases; Behavior, Animal; Brain; Brain Chemistry; Depression; Dopamine; Dopamine Agonists; Dopamine Antagonists; Lupus Erythematosus, Systemic; Male; Mice; Mice, Inbred MRL lpr; Norepinephrine; Quinpirole; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Statistics as Topic; Synaptic Transmission | 2002 |
Safe treatment for depression after heart attack.
Topics: Antidepressive Agents; Depression; Humans; Myocardial Infarction; Sertraline | 2002 |
Audioverbal cognitive dysfunction in depression. Factors involved.
Topics: Adolescent; Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Attention; Cognition Disorders; Depression; Female; Humans; Imipramine; Male; Memory Disorders; Middle Aged; Reaction Time; Sertraline; Severity of Illness Index; Task Performance and Analysis | 2003 |
Dissociative symptoms from combined treatment with sertraline and trazodone.
Topics: Adult; Antidepressive Agents; Depression; Dissociative Disorders; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Trazodone | 2003 |
Sertraline-induced hyperglycemia: case report.
Topics: Antidepressive Agents; Depression; Diabetes Mellitus, Type 2; Female; Humans; Hyperglycemia; Middle Aged; Sertraline | 2003 |
Antidepressants may temper heart-disease risk.
Topics: Antidepressive Agents; Depression; Female; Humans; Male; Middle Aged; Myocardial Infarction; Sertraline | 2003 |
Severe hyponatremia associated with the combined use of thiazide diuretics and selective serotonin reuptake inhibitors.
Topics: Aged; Aged, 80 and over; Depression; Diuretics; Female; Humans; Hydrochlorothiazide; Hypertension; Hyponatremia; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sodium Chloride Symporter Inhibitors | 2004 |
Symptomatic reversible duodenal compression due to iatrogenic retroperitoneal hematoma.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Depression; Drug Interactions; Duodenal Diseases; Female; Hematoma; Humans; Intestinal Obstruction; Middle Aged; Retroperitoneal Space; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulfonamides; Tomography, X-Ray Computed | 2004 |
Serotonin syndrome in the differential diagnosis of spinal cord compression.
Topics: Aged; Aged, 80 and over; Depression; Diagnosis, Differential; Humans; Male; Prostatic Neoplasms; Selective Serotonin Reuptake Inhibitors; Serotonin Syndrome; Sertraline; Spinal Cord Compression; Spinal Neoplasms | 2004 |
A claims analysis comparing citalopram with sertraline as initial pharmacotherapy for a new episode of depression: impact on depression-related treatment charges.
Topics: Adolescent; Adult; Aged; Citalopram; Cohort Studies; Costs and Cost Analysis; Depression; Female; Humans; Male; Middle Aged; Patient Compliance; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
[Sertraline and acute pancreatitis: a case-report].
Topics: Acute Disease; Depression; Female; Humans; Middle Aged; Pancreatitis; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
Topics: Animals; Antidepressive Agents; Citalopram; Depression; Desipramine; Dopamine beta-Hydroxylase; Droxidopa; Fluoxetine; Gene Deletion; Mice; Morpholines; Norepinephrine; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Tail | 2004 |
Transient neonatal jitteriness due to maternal use of sertraline (Zoloft).
Topics: Antidepressive Agents; Depression; Female; Fetus; Humans; Infant, Newborn; Male; Neonatal Abstinence Syndrome; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Neonatal complications after intrauterine exposure to SSRI antidepressants.
Topics: Antidepressive Agents; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; France; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Evaluation of cognitive function of fluoxetine, sertraline and tianeptine in isolation and chronic unpredictable mild stress-induced depressive Wistar rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cognition Disorders; Depression; Female; Fluoxetine; Male; Rats; Rats, Wistar; Sertraline; Stress, Physiological; Thiazepines | 2003 |
The use of atomoxetine adjunctively in fibromyalgia syndrome.
Topics: Adult; Antidepressive Agents; Atomoxetine Hydrochloride; Depression; Female; Fibromyalgia; Humans; Propylamines; Sertraline | 2004 |
Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety.
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Bupropion; Citalopram; Cyclohexanols; Depression; Drug Therapy; Fluoxetine; Humans; Paroxetine; Patient Satisfaction; Primary Health Care; Psychiatry; Psychology; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Work | 2004 |
Antidepressant-induced sexual dysfunction treated with vardenafil.
Topics: Adult; Antidepressive Agents; Depression; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Sertraline; Sexual Dysfunction, Physiological; Sulfones; Triazines; Vardenafil Dihydrochloride | 2004 |
My life on meds.
Topics: Antidepressive Agents; Depression; History, 20th Century; History, 21st Century; Quality of Life; Self Concept; Sertraline | 2004 |
Zoloft helps prevent depression relapse.
Topics: Antidepressive Agents; Depression; Humans; Secondary Prevention; Sertraline | 2004 |
Symptomatic depression after long-term steroid treatment: a case report.
Topics: Adult; Antidepressive Agents; Depression; Dose-Response Relationship, Drug; Glucocorticoids; Hepatitis C, Chronic; Humans; Male; Obsessive-Compulsive Disorder; Prednisone; Sertraline | 2004 |
Bereavement in late life: risk factors for complicated bereavement.
Topics: Adaptation, Psychological; Aged; Antidepressive Agents; Attitude to Death; Bereavement; Counseling; Depression; Humans; Male; Physician-Patient Relations; Psychotherapy; Risk Factors; Sertraline | 2005 |
Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and citalopram.
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents; Anxiety Disorders; Citalopram; Cohort Studies; Depression; Female; Humans; Male; Middle Aged; Paroxetine; Patient Compliance; Patient Dropouts; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic | 2005 |
Bleeding induced by SSRIs.
Topics: Adult; Depression; Hematuria; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 2005 |
Less is more: inpatient management of a child with complex pharmacotherapy.
Topics: Aggression; Amphetamines; Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Depression; Dibenzothiazepines; Domestic Violence; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Irritable Mood; Length of Stay; Male; Methylphenidate; Patient Admission; Psychiatric Department, Hospital; Psychomotor Agitation; Psychotropic Drugs; Quetiapine Fumarate; Recurrence; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Valproic Acid | 2006 |
Comparison of first refill rates among users of sertraline, paroxetine, and citalopram.
Topics: Adolescent; Adult; Anxiety Disorders; Citalopram; Cohort Studies; Cost Sharing; Databases, Factual; Depression; Drug Prescriptions; Female; Humans; Logistic Models; Male; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2006 |
Pharmacological management of a teen with significant alcohol use and depression.
Topics: Adolescent; Alcoholism; Antidepressive Agents; Depression; Female; Humans; Naltrexone; Narcotic Antagonists; Sertraline | 2006 |
Tardive dystonia-associated prescription of aripiprazole.
Topics: Adult; Antidepressive Agents, Second-Generation; Chorea; Depression; Epilepsy, Tonic-Clonic; Gait Disorders, Neurologic; Humans; Male; Sertraline | 2006 |
Imipramine-induced facial pigmentation: case report and literature review.
Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Antidepressive Agents, Tricyclic; Depression; Facial Dermatoses; Female; Humans; Hyperpigmentation; Imipramine; Male; Microscopy, Electron; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Skin; Staining and Labeling; Time Factors | 2005 |
[Anabolic-catabolic balance in depression: an effect of coaxil].
Topics: Adult; Antidepressive Agents, Tricyclic; Dehydroepiandrosterone Sulfate; Depression; Energy Metabolism; Female; Follow-Up Studies; Humans; Hydrocortisone; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Thiazepines; Treatment Outcome | 2006 |
Treatment of postpsychotic depression with sertraline in patients with schizophrenia--own experience.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression; Female; Humans; Imipramine; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Sertraline; Treatment Outcome | 2006 |
Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression.
Topics: Adolescent; Child; Child, Preschool; Depression; Epilepsy; Female; Fluoxetine; Humans; Male; Neurologic Examination; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 2007 |
Amenorrhea after sertraline introduction in an amisulpride-treated patient with undiagnosed polycystic ovary disease.
Topics: Adult; Amenorrhea; Amisulpride; Antipsychotic Agents; Depression; Drug Interactions; Female; Humans; Hyperprolactinemia; Polycystic Ovary Syndrome; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulpiride | 2007 |
Therapeutic alliance and treatment preference.
Topics: Antidepressive Agents; Depression; Humans; Patient Satisfaction; Professional-Patient Relations; Psychotherapy; Randomized Controlled Trials as Topic; Sertraline | 2007 |
Episode of major depression refractory to pharmacotherapy.
Topics: Adult; Depression; Female; Humans; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Failure | 2006 |
Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.
Topics: Aged; Aged, 80 and over; Algorithms; Bayes Theorem; Citalopram; Cost-Benefit Analysis; Depression; Drugs, Generic; Female; Fluoxetine; Humans; Male; Medicare; Models, Statistical; Paroxetine; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States | 2007 |
Sertraline-induced hyponatremia in the elderly.
Topics: Aged; Depression; Humans; Inappropriate ADH Syndrome; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Sodium | 2007 |
Sertraline treatment for depression associated with acute coronary syndromes: a cost analysis from the viewpoint of the Italian Healthcare System.
Topics: Acute Coronary Syndrome; Aged; Antidepressive Agents; Cost-Benefit Analysis; Costs and Cost Analysis; Delivery of Health Care; Depression; Diagnosis-Related Groups; Economics, Pharmaceutical; Humans; Italy; Middle Aged; Sertraline | 2008 |
Realities of the fluoxetine-to-sertraline switch.
Topics: 1-Naphthylamine; Cost-Benefit Analysis; Depression; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Tablets | 1995 |
Sudden chest pain with sertraline.
Topics: 1-Naphthylamine; Antidepressive Agents; Aspirin; Chest Pain; Coronary Disease; Depression; Humans; Male; Middle Aged; Nortriptyline; Propranolol; Sertraline | 1994 |
Sudden chest pain with sertraline.
Topics: 1-Naphthylamine; Antidepressive Agents; Chest Pain; Depression; Electrocardiography; Heart; Humans; Male; Reference Values; Sertraline | 1994 |
Pharmacologic management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Anxiety Disorders; Clomipramine; Depression; Dopamine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Synaptic Transmission; Trazodone | 1994 |
Possible interaction between sertraline and tranylcypromine.
Topics: 1-Naphthylamine; Clonazepam; Depression; Drug Administration Schedule; Drug Interactions; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Tranylcypromine | 1993 |
A 61-year-old man with Parkinson's disease.
Topics: 1-Naphthylamine; Antiparkinson Agents; Carbidopa; Depression; Dopamine Agents; Drug Interactions; Drug Therapy, Combination; Family Practice; Humans; Levodopa; Male; Middle Aged; Neurology; Neuroprotective Agents; Parkinson Disease; Selegiline; Sertraline; Vitamin E | 1996 |
Incentive bias?
Topics: 1-Naphthylamine; Clinical Trials as Topic; Depression; Drug Administration Schedule; Drug Costs; Drug Industry; Financial Support; Humans; Paroxetine; Prejudice; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
An open trial of adjunctive sertraline in the treatment of chronic schizophrenia.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antipsychotic Agents; Chronic Disease; Delayed-Action Preparations; Depression; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Schizophrenia; Schizophrenic Psychology; Sertraline; Treatment Outcome | 1996 |
[The clinicopharmacological case (5). serotonin reuptake inhibitor and 5-HT3-receptor antagonists: are there clinically relevant interactions?].
Topics: 1-Naphthylamine; Antidepressive Agents; Antiemetics; Depression; Drug Interactions; Female; Humans; Ondansetron; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Sertraline | 1996 |
Sertraline for nocturnal enuresis.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Depression; Enuresis; Humans; Male; Sertraline | 1997 |
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
Topics: 1-Naphthylamine; Aggression; Animals; Anxiety; Binding, Competitive; Citalopram; Depression; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Rats; Rats, Wistar; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sertraline; Vocalization, Animal | 1997 |
Awareness of potential drug interactions may aid avoidance.
Topics: 1-Naphthylamine; Amiodarone; Anti-Arrhythmia Agents; Antidepressive Agents; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depression; Drug Interactions; Humans; Male; Middle Aged; Mixed Function Oxygenases; Sertraline | 1997 |
Medication-induced seizures.
Topics: 1-Naphthylamine; Adolescent; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Depression; Drug Therapy, Combination; Humans; Male; Methylphenidate; Seizures; Sertraline | 1997 |
Sertraline, a selective serotonin reuptake inhibitor, unmasking carcinoid syndrome.
Topics: 1-Naphthylamine; Carcinoid Tumor; Depression; Female; Humans; Liver Neoplasms; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
[Advances in depression therapy. Sertralin: highly selective SSRI with low interaction potential].
Topics: 1-Naphthylamine; Depression; Drug Interactions; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Pindolol augmentation of sertraline in resistant depression and its effect on sleep.
Topics: 1-Naphthylamine; Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Brain; Depression; Drug Synergism; Electroencephalography; Female; Humans; Pindolol; Serotonin; Sertraline; Sleep | 1998 |
Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
Topics: Animals; Antidepressive Agents; Buspirone; Citalopram; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exercise Test; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming | 1998 |
Visual hallucinations associated with fluoxetine and sertraline.
Topics: Adult; Antidepressive Agents; Depression; Fluoxetine; Hallucinations; Humans; Male; Sertraline | 1998 |
Activity and onset of action of reboxetine and effect of combination with sertraline in an animal model of depression.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amygdala; Analgesics; Animals; Antidepressive Agents; Body Temperature; Clonidine; Depression; Disease Models, Animal; Drug Therapy, Combination; Exploratory Behavior; Hydroxyindoleacetic Acid; Male; Morpholines; Motor Activity; Olfactory Bulb; Rats; Rats, Sprague-Dawley; Reboxetine; Serotonin Receptor Agonists; Sertraline; Swimming | 1999 |
Sertraline, a selective serotonin reuptake inhibitor modulates extracellular noradrenaline in the rat frontal cortex.
Topics: Animals; Depression; Dopamine; Hippocampus; Male; Norepinephrine; Prefrontal Cortex; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Sertraline. A pharmacoeconomic evaluation of its use in depression.
Topics: 1-Naphthylamine; Antidepressive Agents; Depression; Health Care Costs; Humans; Sertraline | 1997 |
Stevens-Johnson syndrome after sertraline.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Depression; Drug Eruptions; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Stevens-Johnson Syndrome | 1999 |
Association of maternal sertraline (Zoloft) therapy and transient neonatal nystagmus.
Topics: Antidepressive Agents; Depression; Female; Humans; Infant, Newborn; Intensive Care, Neonatal; Muscle Hypotonia; Nystagmus, Congenital; Pregnancy; Pregnancy Complications; Sertraline | 1999 |
Sertraline in the treatment of mixed anxiety and depression disorder.
Topics: Adult; Anxiety; Depression; Female; Humans; Male; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Sequential improvement of anxiety, depression and anhedonia with sertraline treatment in patients with major depression.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Depression; Female; Humans; Male; Middle Aged; Patient Compliance; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
An 82-year-old woman with mood changes following a stroke, 1 year later.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Antidepressive Agents; Depression; Female; Humans; Mood Disorders; Nortriptyline; Sertraline; Stroke; Stroke Rehabilitation | 2001 |
Induction of cysteine string protein after chronic antidepressant treatment in rat frontal cortex.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Depression; DNA, Complementary; Frontal Lobe; Gene Expression Regulation; HSP40 Heat-Shock Proteins; Imipramine; Male; Membrane Proteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sertraline | 2001 |
Prefrontal changes and treatment response prediction in depression.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder, Major; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Prefrontal Cortex; Sertraline; Venlafaxine Hydrochloride | 2001 |
A case of antidepressant-induced akathisia in a patient with traumatic brain injury.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Brain Injuries; Depression; Diagnosis, Differential; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors.
Topics: Coronary Disease; Depression; Flow Cytometry; Humans; In Vitro Techniques; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Receptors, Cell Surface; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Prevalence and recognition of depressive symptoms among homebound older adults with urinary incontinence.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Depression; Female; Homebound Persons; Humans; Male; Middle Aged; Prevalence; Sertraline; Severity of Illness Index; Surveys and Questionnaires; Urinary Incontinence | 2001 |
Cross-sensitivity between paroxetine and sertraline.
Topics: Adult; Depression; Drug Eruptions; Exanthema; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
SSRIs: take your pick.
Topics: Depression; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Multiple anomalies in a fetus exposed to low-dose methotrexate in the first trimester.
Topics: Abnormalities, Multiple; Adolescent; Bone and Bones; Craniofacial Abnormalities; Depression; Digestive System; Digestive System Abnormalities; Female; Fetal Death; Heart Defects, Congenital; Humans; Infant, Newborn; Methotrexate; Pregnancy; Pregnancy Complications; Pregnancy Trimester, First; Psoriasis; Sertraline; Ultrasonography, Prenatal | 2002 |
If at first you do succeed.
Topics: 1-Naphthylamine; Antidepressive Agents; Benzamides; Depression; Fluoxetine; Half-Life; Humans; Moclobemide; Receptors, Serotonin; Serotonin Antagonists; Sertraline | 1991 |
The platelet serotonergic system in depression and following sertraline treatment.
Topics: 1-Naphthylamine; Blood Platelets; Depression; Female; Humans; Male; Naphthalenes; Platelet Aggregation; Radioligand Assay; Receptors, Serotonin; Serotonin; Sertraline | 1988 |